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A major risk factor for the development of type 2 diabetes is reduced skeletal 
muscle insulin sensitivity. It is known that exercise and caloric restriction can improve 
skeletal muscle insulin resistance, but the mechanism by which this occurs is not 
completely elucidated. The AMP-activated protein kinase (AMPK), is thought to be a 
major contributor to the metabolic benefits observed after exercise training and caloric 
restriction. Activation of AMPK in skeletal muscle can have a wide range of effects, one 
of which is the initiation of macroautophagy (herein referred to as autophagy). Autophagy 
is the bulk degradation system of the cell and is essential for the maintenance of cellular 
homeostasis. Another intervention that has been shown to have insulin sensitizing effects 
and activation of AMPK, is heat treatment. Heat treatment consists of acute bouts of low 
heat loads. Although high heat loads have been shown to regulate autophagy, whether low 
heat loads given with heat treatment can regulate autophagy has yet to be investigated. 
Additionally, the role that autophagy plays in the heat-induced insulin sensitization of 
skeletal muscle has not been investigated. Thus, the aims for the following studies were to 
investigate autophagy regulation with heat treatment and to identify what role autophagy 
may have in the insulin sensitizing effects of heat treatment in insulin resistant skeletal 
muscle cells. 
Here we show that heat treatment activates protein signaling involved in the 
initiation of autophagy and autophagosome formation in skeletal muscle cells. 
Additionally, when autophagy was inhibited, heat treatment was able to decrease 
autophagosomal accumulation. This suggests that heat can increase basal autophagy, and 
potentially rescue autophagic flux when inhibited. When myotubes were treated with 
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palmitate, insulin signaling decreased, autophagy initiation was blunted, autophagosomal 
accumulation occurred, and cell stress markers were elevated. Heat treatment was able to 
reduce some markers of insulin resistance, reduce cell stress markers, and partially drive 
autophagosomal degradation. When autophagy was inhibited, the mild attenuation of 
insulin resistance was removed. This suggests that autophagy plays a role in insulin 
sensitization, and that heat treatment may attenuate insulin resistance, at least partially 
through the induction of autophagy, but further investigation is necessary to understand the 
extent or magnitude of this role.
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CHAPTER 1.    INTRODUCTION 
All cells, tissues, and organisms function best within a relatively narrow 
temperature range [1, 2]. If this homeostasis is disturbed, there can be severe consequences 
at the cellular and organismal levels. As our climate continues to change, it is expected that 
extreme heat events will become more common, severe, and longer-lasting [3]. Extreme 
heat causes more fatalities than any other weather-related hazard, and each summer more 
than 65,000 Americans are admitted to hospital care due to acute heat illness [4]. Although 
prolonged exposure to environmental heat is the main cause for heat-related illnesses and 
injuries, it is not the only source. To prevent exertional heat injuries, the heat generated by 
the muscles must be effectively transported to the skin and dissipated to the environment, 
however there is still a rise in core body temperature. Basal temperatures of skeletal muscle 
in rats has been shown to be ~36°C, while rat basal rectal temperature is ~38.3°C [5]. 
During moderate exercise in rats, the heat production from skeletal muscle contraction can 
increase skeletal muscle and rectal temperatures to ~40°C, while exhaustive exercise in 
rats can increase skeletal muscle temperature ~44°C and rectal temperature to ~43°C [5]. 
Additionally, in humans, it has been shown that muscle temperatures at rest are roughly 
~35°C, but with the onset of submaximal exercise, will surpass rectal temperatures within 
3-5 minutes and reach equilibrium, ~39°C, within 10-20 minutes [6]. Despite exertional 
heat stroke being among the leading causes of on-the-field sudden deaths in athletes, 
beneficial effects of acute bouts of low heat load heating have been reported [7]. 
Type 2 diabetes is characterized by insulin resistance, elevated fasting blood 
glucose levels, and elevated glycated hemoglobin (HbA1c) [8]. When glucose enters the 
bloodstream, it attaches to the hemoglobin in the circulating red blood cells, forming 
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HbA1c. Higher levels of HbA1c increase the risk of developing diabetes-related 
complications. These high HbA1c levels are due to the elevated plasma glucose levels, 
which in turn are due to the insulin resistant tissues [8]. Insulin-sensitive tissues, primarily 
skeletal muscle, adipose tissue, and the liver, respond to insulin by increasing glucose 
uptake, thus decreasing plasma glucose levels. When these tissues become insulin resistant, 
glucose cannot be removed from the blood and type 2 diabetes can be the result. Skeletal 
muscle tissue is responsible for the majority of the insulin-stimulated glucose uptake in the 
body [9]. The contraction of skeletal muscle can induce glucose uptake, independent of 
insulin stimulation [10]. Additionally, exercise training has been shown to improve whole 
body insulin-stimulated glucose uptake [11]. So, perhaps the benefits seen by exercise are 
not solely from contraction, but also from the heat generated by the contracting muscle. 
Interestingly, when type 2 diabetics were partially immersed in a hot tub set to 37.8-
41°C, 30 minutes a day, six days a week, for three weeks, there was a significant reduction 
in their mean fasting plasma glucose and glycosylated hemoglobin levels [12]. The lower 
body immersion of high-fat diet fed rats in a hot bath was also done and showed similar 
improvements in insulin resistance. This study showed that one 20 minute bout of heat 
treatment at 41°C per week, for 12 weeks, could significantly attenuate the insulin 
resistance effects of a high-fat diet [13]. These studies show how mild short-term heating 
can have beneficial effects, but the mechanism behind these effects of heat have yet to be 
elucidated. There is evidence to suggest that the heat shock response may be responsible 
for the therapeutic effects of heat treatment [13]. When the major inducible heat shock 
protein, Hsp70 (also referred to as Hsp72), was overexpressed in mice, a high-fat diet did 
not induce insulin resistance [14]. The majority of the research into heat stress and heat 
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treatment involves the heat shock response (HSR) and the heat shock proteins (HSPs). Yet, 
the heat shock response has many roles within cells and interacts with many pathways. One 
major cellular maintenance pathway that the heat shock response interacts with is 
autophagy.  
Autophagy is a self-digestive process that is present in all mammalian cells at a 
basal, homeostatic level, but may be activated or dysregulated by a variety of stressors [15]. 
Autophagy is characterized by the engulfment of cytosolic material by double membrane 
vesicles, termed autophagosomes, and their subsequent fusion with and degradation by 
lysosomes. These degraded products are then used as energy sources or building blocks for 
further cellular metabolic processes. There are two main proteolysis pathways, the 
ubiquitin-proteasome system (UPS) and autophagy. UPS is the major proteolysis pathway 
that does not require lysosomal enzymes for its degradation. The UPS mainly targets the 
short-lived, misfolded, and damaged proteins, but can also degrade long-lived proteins 
[16]. However, the size of the proteasomes involved in UPS causes an obvious limitation 
to the size of the complex that this process can degrade. This is where the larger size of the 
autophagosomes in autophagy can benefit the cell by degrading larger, longer-lived 
proteins, as well as organelles, protein aggregates, or invasive pathogens [17]. Due to its 
critical responsibilities of macromolecular turnover, autophagy is a very tightly regulated 
process during basal conditions, but this regulation becomes ever more apparent during 
times of intense stress [18].  
Heat stress denatures cellular proteins, induces protein aggregation, and increases 
metabolic activity, so it is not surprising that heat would have a complex effect on 
autophagy [19]. However, whether the low heat load of heat treatment is a strong enough 
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stressor to alter autophagy and/or whether autophagy is a component of the heat treatment-
induced insulin-sensitizing effects, is still unknown. Although autophagy is highly 
conserved, the nomenclature and the pathways that regulate or are regulate by autophagy 
vary between species [20]. Although there are is an abundance of research regarding 
autophagy in different model systems, this thesis will focus solely on mammalian 
autophagy. [21-24]. 
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CHAPTER 2.    LITERATURE REVIEW 
Autophagy, literally meaning “self-eating”, is an essential intracellular degradation 
system that is highly conserved amongst eukaryotes, yeast, and plants [1]. The importance 
for this pathway across species is seen through its roles to remove aggregated proteins, 
damaged organelles, and intracellular pathogens [2]. There exist three basic forms of 
autophagy that coexist within all mammalian cells: microautophagy, chaperone-mediated 
autophagy, and macroautophagy (Figure 1) [3]. Microautophagy is mediated by direct 
lysosomal engulfment of the cargo. This form constitutes a considerably small portion of 
the overall system, while chaperone-mediated autophagy and macroautophagy play much 
larger roles [3]. Chaperone-mediate autophagy (CMA) occurs when chaperones, mainly 
heat shock proteins (HSPs), transport proteins marked for degradation from the cytosol 
directly to the lysosomes. Macroautophagy (herein referred to as autophagy) utilizes a 
double-membrane bound vesicle, termed autophagosome, which forms around bulk 
cytosolic material and later fuses with a lysosome, to form an autolysosome. The 
sequestered cytosolic constituents are then degraded by lysosomal hydrolases and released 
back into the cytosol for nutrient recycling. Autophagy is largely a non-selective 
degradation system, however there exists another form of autophagy, selective autophagy, 




Figure 1. The three main forms of autophagy. 
Molecular Mechanisms of Autophagy 
The process of autophagy can be broken down into four general stages: induction, 
vesicle nucleation, vesicle elongation, and fusion and degradation. The first stage is the 
induction stage, which is initiated mainly through the activation of the ULK1 complex [4]. 
The second stage, vesicle nucleation, is sometimes grouped with either stage 1 or stage 3, 
assumingly for simplicity, but this stage involves several protein complexes working 
together to create an autophagosome precursor, an isolation membrane [5, 6]. With the 
third stage of autophagy, the isolation membrane, that was created during stage 2, is now 
being elongated, sequestering intracellular material, and finally forming a fully enclosed 
double membrane vesicle, termed the autophagosome [6, 7]. The final stage involves the 
fusion of the autophagosome with a lysosome and the subsequent degradation of the 
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sequestered material by hydrolases [6]. Here I outline the various stages of autophagy, and 
the proteins involved, in greater detail. 
Induction 
The induction of autophagy begins with the ULK1/2 complex. There are four ULK 
family members, but only ULK1 and ULK2 are thought to be involved with autophagy. 
There is evidence that in certain cell types, at least, ULK1 has a much larger role in 
autophagy regulation than ULK2 [8-12]. Although, recent research has shown that ULK2 
may regulate a different part of the autophagic pathway, specifically p62 accumulation 
[13]. The ULK1 complex consists of several proteins: ULK1 (serine-threonine kinase), 
Atg13, FIP200, and Atg101 [14, 15]. The activation of this initiation complex is regulated 
by mTOR, which is a highly conserved serine-threonine kinase that belongs to the PI3K-
related kinase family. When mTOR is activated, due to nutrient excess for instance, ULK1 
is phosphorylated at Serine 757, which renders it enzymatically inactive [4, 16]. However, 
when mTOR is inhibited, by nutrient deficit or rapamycin, ULK1 is dephosphorylated at 
Serine 757 and can phosphorylate both Atg13 and FIP200, commencing autophagy [16, 
17]. 
Adenosine monophosphate (AMP)-activated protein kinase (AMPK), an antagonist 
to mTOR, is an energy-sensing molecule that becomes activated during times where the 
AMP to ATP ratio (AMP/ATP) is significantly increased above basal levels (i.e. energy 
deficit) [4, 18]. This molecule, while being vastly studied for its anti-aging, anti-diabetic, 
and anti-cancer properties, is also a prime regulator of the autophagic pathway [19-25]. 
When AMPK is phosphorylated at Threonine 172, it becomes highly active, regulating 
many downstream metabolic processes [21, 26]. One of those processes is autophagy, 
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through direct association and phosphorylation of ULK1 at several sites, Serine 317, 555, 
and 777 [8, 27]. Activated AMPK will also inhibit mTOR, thus also providing an indirect 
activation of the ULK1 complex. Though activated AMPK will inhibit mTOR, unless 
amino acids are severely depleted, there will be some residual mTOR activation. Thus, 
AMPK and mTOR act in concert to tightly regulate autophagy. 
Vesicle nucleation 
The class III phosphoinositide 3-kinase (PI3K) complex is required for the 
nucleation of the autophagosome membrane [28]. This complex is composed of hVps34 
(also known as PI3K Class III), Beclin-1, p150, AMBRA1, and Atg14L [28, 29]. Typically, 
Bcl-2 is bound to Beclin-1, preventing it from promoting autophagy [30]. However, once 
activated, ULK1 directly phosphorylates Beclin-1 at Serine 14, allowing Beclin-1 to 
dissociate from Bcl-2 and activate PI3K Class III. Atg14L association with Beclin-1, 
allows for a more efficient substrate for ULK1 phosphorylation [31]. The class III PI3K 
complex can associate with a membrane, since p150 is N-terminally myristoylated and 
anchors the complex to the membrane [32, 33]. The source of the membrane in mammals 
is much more complex than in other species. In mammalian cells, the isolation membranes 
form from varying locations within the cell, depending on the purpose [5, 34]. Whereas in 
yeast, there exists a single site of organization for vesicle formation, termed the pre-
autophagosomal structure (PAS) [35]. The isolation membrane in mammalian cells, 
regardless of its origin, seems to be the yeast PAS counterpart. Some commonly believed 
origin membranes for the isolation membrane are cytoplasmic membrane, Golgi apparatus, 
endoplasmic reticulum, and the mitochondria [34]. For mitophagy, there seems compelling 
evidence that mitochondrial-associated membranes (MAMs), portions of the endoplasmic 
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reticulum membrane that are modified to interact with mitochondria, could be the source 
locations [7]. Regardless of the membrane source, once the class III PI3K complex is 
associated with a membrane, activated PI3K Class III catalyzes the conversion of PI to 
PI3P [36]. An accumulation of PI3P in the associated membrane begins the formation of 
the pre-autophagosome.  
Vesicle elongation 
The highly abundant PI3P that is generated by PI3K Class III activity allows for 
the PI3P effectors WIPI1 and WIPI2 to bind, initiating the elongation of the 
autophagosome [36]. WIPI association will recruit lipid complexes for further growth of 
the autophagosome as well as the essential anchoring proteins that allow for cargo to be 
sequestered [37]. Two ubiquitination-like reactions occur that all for complete 
autophagosome formation. The first of the reaction will result in the formation of the 
Atg16L complex, which is dimerization of a complex composed of Atg12, Atg5, and Atg16 
[38, 39]. First, Atg12 associates with Atg7 (an E1-like protein). Atg12 then gets transferred 
from Atg7 to Atg10 (an E2-like protein). Atg12 once again gets transferred to Atg5, which 
then can associate with Atg16. Two separate Atg12-Atg5-Atg16 complexes dimerize by 
association of the Atg16 components, forming the Atg16L complex [39]. This complex 
then associates with the WIPI proteins attached to the elongating phagophore. The second 
ubiquitination-like reaction results in the formation of LC3-II, the main marker used to 
identify and track autophagosome formation and accumulation [40-44]. The translated 
form of LC3, proLC3, exists transiently, due to the extremely high activity of Atg4, which 
cleaves the carboxyl end of proLC3, exposing a terminal Glycine. This cleaved version of 
proLC3 is referred to as LC3-I. The exposed carboxyl terminal Glycine of LC3-I is a prime 
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target for the E1-like protein, Atg7, which binds to it temporarily, until it passes it off to 
the E2-like protein, Atg3 [45]. 
Once the LC3-Atg3 complex is formed, the affinity of Atg3 for Atg12, brings the 
LC3-Atg3 complex to the Atg16L-WIPI-PI3P associations on the growing phagophore 
[39]. Now that the LC3-Atg3 complex is in close proximity to a membrane, a 
phosphatidylethanolamine (PE) within the membrane has a much higher affinity for LC3 
than does Atg3, thus LC3-II (LC3-PE) is formed [46]. There also exists other relatives of 
LC3, such as GABARAP and GATE16, which act in similar manners, but to a lesser extent. 
However, there is a growing body of research in just how involved GABARAP is in this 
pathway [47]. LC3-II acts as an anchoring protein for sequestered cargo, and with the 
growing LC3-II abundance on both sides of the autophagosome, sequestered material can 
be secured into the vesicle. However, there exists another very important protein that acts 
as an adaptor between potential cargo and the LC3-II embedded in the autophagosome. 
The most popularly investigated of these adaptor proteins is p62 (also referred to as 
SQSTM1), and it is another essential marker for monitoring autophagosome formation and 
accumulation [48, 49]. Other adaptor proteins that are involved in this process, but to a 
much lesser extent, are optineurin, NDP53, NBR1, NIX, and Alfy [49-51]. For p62 to 
associate with a variety of potential cargo, there must exist a commonality between the 
targets, which is their ubiquitination [49]. 
Fusion and degradation 
 Once fully formed, autophagosomes then fuse with lysosomes (or endosomes) for 
the degradation of their contents. The LC3-II integrated into the outer side of the fully 
formed autophagosome allows for the association with the dynein-dynactin motor protein 
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complex and its nearly exclusive retrograde travel along the microtubules. Simultaneous 
lysosomal anterograde travel along the microtubules, via the kinesin motor protein, 
eventually brings the two vesicles into proximity for the appropriate SNARE proteins to 
associate and fusion to occur [52-54]. Once the autophagosome and lysosome fuse, the 
autolysosome forms. The lipidated LC3 on the outer portion of the autophagosome 
membrane begins to be cleaved by Atg4 into the non-membrane-bound LC3-I [46]. Within 
the lumen of the autolysosome, the high acidity allows for hydrolase degradation and 
recycling of the interior contents. 
Regulation of Autophagy 
Nutrient regulation 
The upregulation of autophagy when the cell is under metabolic stress can supply 
the necessary nutrients for the essential production of ATP and stress-response proteins 
[55, 56]. In response to metabolic stress, such as nutrient deprivation, growth factor 
depletion, or hypoxia, autophagy’s activation acts as a survival response [57]. This survival 
response will impede apoptosis, at least for a time, by generating free glucose, amino acids, 
and fatty acids that can be recycled intracellularly or distributed to distant tissues [58]. The 
disenthralled glucose, amino acids, and fatty acids can be used for the production of cellular 
ATP [58]. In autophagy-deficient cells, some of the negative characteristics associated with 
dysregulated autophagy can be corrected by the administration of certain TCA substrates, 
suggesting that autophagy plays a critical role in supplying substrates for cellular 
respiration [59, 60]. The amino acids freed by autophagy will also be used for the de novo 
synthesis of critical stress response proteins [61, 62]. As well, the carbohydrate and lipid 
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stores that are digested through autophagy are used for synthesis of glycolipids, 
glycoproteins, or membrane lipids [63]. These essential metabolic regulations could 
underlie some of the reasons for the seemingly critical function of autophagy and its 
evolutionarily conserved prosurvival effects. As discussed previously, autophagy operates 
differently in a basal and stimulated states. While there is considerable overlap in the 
pathways and proteins utilized by both forms to sequester and degrade cytoplasmic 
constituents, the processes of activation and regulation differ. The most studied form of 
autophagy is that of the stimulated state, using models of nutrient deprivation [41, 43, 64, 
65]. 
Amino acids 
Amino acids are the most potent of the macromolecules in terms of autophagy 
regulatory capacity. Specifically, it is the branched chain amino acids, of which Leucine is 
by far the most potent, that interact with mTORC1 to regulate metabolism and autophagy 
[66]. When intracellular levels of amino acids are low, the abundance of amino acids within 
the lysosome are also low. In this low amino acid state, the lysosomal v-ATPase—
Ragulator—Rag GTPase complex is in an inactive conformation and cannot associate with 
and activate mTORC1. However, when the intracellular and lysosomal abundance of 
amino acids is high, the v-ATPase—Ragulator—Rag GTPase complex shifts into a 
conformationally-active form, recruiting mTORC1 to the lysosomal surface. Once 
recruited to the lysosomal surface, mTORC1 is then activated via the small GTPase Rheb 
[67]. The activated mTORC1 then stimulates anabolic signaling and inhibits catabolic 
signaling through several targets, such as S6K, 4E-BP1, ULK1, and TFEB. The 
phosphorylation of the anabolic targets of mTORC1, S6K and 4E-BP1, stimulate protein 
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synthesis, while the phosphorylation of ULK1 and TFEB prevent catabolism [68]. TFEB 
is a master regulator of lysosomal biogenesis and, during amino acid deprivation, it 
translocates to the nucleus to induce transcription of catabolic genes. Upon 
phosphorylation by mTORC1, TFEB cannot dissociate from the lysosome and does not 
activate the catabolic genes [69].  
Glucose 
Glucose is another key regulator of autophagy and metabolism. In conditions where 
the levels of glucose become depleted, the cellular AMP:ATP ratio increases, activating 
AMPK [70]. Activated AMPK then inhibits mTORC1 both directly and indirectly via the 
phosphorylation of raptor and TSC2, respectively. AMPK not only prevents the inhibition 
of autophagy by mTOR, but it also phosphorylates and activates ULK1 and Beclin-1, 
activating autophagy directly [4, 8, 27]. Glucose deprivation can also induce autophagic 
activity in skeletal muscle through the deacetylation of FOXO1 by SIRT1, which then 
allows FOXO1 to activate genes involved in autophagosome formation [71]. Not only does 
glucose deprivation activate autophagy by multiple processes, but the activated autophagy 
can directly degrade glycogen stores, thereby providing necessary glucose for the cellular 
respiration [72]. 
Lipids 
Similar to proteins and carbohydrates, lipid stores can also be broken down by 
autophagy, in a process known as lipophagy. Along with cytosolic lipases, lipophagy can 
help mobilize non-esterified fatty acids (NEFAs), also called free fatty acids (FFAs), and 
cholesterol that were previously suspended in lipid droplets [73]. Certain fatty acids can 
mediate the activation of autophagy and other intracellular signaling pathways, such as the 
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saturated fatty acid palmitate and the sphingolipid ceramide. Palmitate can increase the 
activation of autophagy through the inhibition of mTORC1 or via the PKR-JNK pathway 
[74]. Ceramide, which is an active participant in obesity-induced insulin resistance, inhibits 
amino acid uptake, suppresses Akt activity, and causes Beclin-1 to dissociate from Bcl-2, 
all leading to the activation of autophagy and, with chronic exposure, autophagic cell death 
[74]. Conversely, excessive lipid concentrations can dysregulate autophagy through the 
interference of the fusion step or by impairing lysosomal activity [75, 76]. 
Additional regulatory pathways 
The constant monitoring and regulation of such a powerful system as autophagy 
requires a complex network of signals to preserve the integrity of the cell [77]. As 
mentioned previously, intracellular nutrient fluctuation can easily disturb the balance of 
these autophagy signals, but there are other signaling pathways and upstream kinases that 
should be taken into account. For instance, we have discussed the importance of mTOR 
activation by its phosphorylation at Serine 2448 through nutrient sensing, but not through 
its interaction with insulin, growth factors, PI3K, and Akt. 
Insulin signaling pathway 
It is well known that after a meal, blood sugar will rise, causing the secretion of 
insulin and subsequently insulin-like growth factors (IGFs), which are key regulators of 
metabolism and growth. When blood sugar rises, insulin is secreted by the pancreatic β-
cells to target skeletal muscle and adipose tissue, which are the major sites of glucose 
uptake, as well as the liver, to decrease gluconeogenesis and increase secretion of IGF1 
[78]. Circulating insulin and IGF1 will make its way to skeletal muscle and adipose tissue, 
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where it will then bind with one of three different isoforms of the insulin/IGF1 receptor 
[79]. Upon reaching the receptor, an intracellular signaling transduction pathway is 
initiated first by the phosphorylation of the intracellular component of the receptor. Once 
phosphorylated, the scaffolding protein insulin receptor substrate (IRS1/2), of which two 
isoforms exist, can bind to the intracellular component of the receptor and act as a binding 
and activation site for phosphoinositide 3-kinase (PI3K) [80, 81]. 
There exist multiple classes of the PI3K protein. PI3K Class I, typically just referred 
to as PI3K, is the kinase that is activated by IRS1/2. The Class I kinase is related to but 
distinct from the PI3K Class III (PI3K CIII) protein that is intricately involved in autophagy 
signaling. Additionally, PI3K can also directly bind to the phosphorylated receptor directly, 
without the need for a scaffolding protein [81]. This interaction of PI3K with IRS1/2 or 
IR/IGF1R will bring it into close proximity of its target, phosphatidylinositol-4,5-
bisphosphate (PIP2), which is a regular component of the intracellular membrane. PI3K 
then phosphorylates PIP2, generating the lipid second messenger phosphatidylinositol-
3,4,5-trisphosphate (PIP3). Akt and PDK1 are then recruited to the membrane via their 
PIP3 binding domains (PH domains) [82]. This allows for Akt to be activated by its 
phosphorylation of Threonine 308 and Serine 473, by PDK1 and mTORC2 respectively 
[83]. Although mTORC2 is an important complex in the regulation of cellular metabolism, 
little is known about its regulation and rapamycin only inhibits it after prolonged exposure 
[84, 85]. Activated Akt phosphorylates many targets, three of which directly play a role in 
the activation of mTORC1 (TSC2, PRAS40, and AMPK) [86, 87]. TSC2 is phosphorylated 
on multiple serine and threonine residues by Akt, allowing for it to function as a GTPase-
activating protein for the small Ras-like protein, Rheb. The phosphorylation of PRAS40 
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weakens its association with and stimulates mTORC1 kinase activity [87]. The inhibitory 
sites of AMPK, Serine 485/491, have been shown to be phosphorylated by Akt in several 
tissues, including adipose and skeletal muscle [88]. The now active mTORC1 can go on to 
fulfill its anabolic and anti-autophagic effects. 
Sirtuin and FoxO signaling 
The sirtuin family of proteins are highly conserved NAD-dependent deacetylase 
that act as energy-sensors for the cell. This family is known primarily for its role in 
mediating the longevity effects seen with caloric restriction in many species [89]. The 
protein Sirtuin 1 (SIRT1) is one of the most extensively studied of this family [90]. SIRT1 
is expressed in nearly all mammalian cells and has been studied in most human metabolic 
tissues [91-93]. Regulation of SIRT1 is primarily through the abundance of NAD+ or the 
ratio of NAD+/NADH [94]. When there is a large amount of NAD+ or a high ratio of 
NAD+/NADH, then SIRT1 is activated and begins deacetylating its targets, which are 
involved in many regulatory pathways, such as cell proliferation, metabolism, and 
resistance to stress. The immediate targets of SIRT1 deacetylation that are involved in the 
regulation of autophagy, are Forkhead box O (FoxO) 1, FoxO3, Atg5, Atg7, and LC3 [95]. 
Similar to AMPK and autophagy, SIRT1 activity has been shown to be upregulated in 
certain tissues during times of nutrient deficit and energy expenditure [96-98]. 
Interestingly, AMPK and SIRT1 seem to regulate each other and share similar targets, 
although modification of those targets would be different [90]. Thus, SIRT1 activity might 
also be an essential process of autophagy regulation. 
The FoxO transcription factor family of proteins have important regulatory roles in 
maintaining cellular homeostasis. FoxO factors, primarily FoxO1 and FoxO3, are key 
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mediators of autophagy in skeletal muscle in response to fasting, denervation, and atrophy 
[99-101]. Upon this nutrient deficit, FoxO1 has been shown to increase the expression of 
cathpsin L, a lysosomal protease, while FoxO3 is responsible for the transcription of key 
autophagy-related genes, such as LC3, BNIP3, GABARAP, and Atg12 [100, 102, 103]. 
SIRT1 seems to also be under the direct regulation of Akt, which phosphorylates FoxO3, 
blocking its nuclear translocation and transcription of autophagy-related genes [103]. 
However, FoxO3 activity was not affected by the addition of rapamycin, which is an 
inhibitor of mTORC1, so the regulation by Akt seems to be independent of the autophagy 
inhibitor mTORC1 [103]. In fasting conditions, FoxO1 and FoxO3 may also induce several 
components of the UPS pathway, such as transcription of the two muscle-specific E3 
ubiquitin ligases atorgin-1/MAFbx and MuRF1, resulting in atrophying of the skeletal 
muscle [81, 104]. Thus, FoxO factors seem to be extremely important in regulating the 
proteolytic pathway in skeletal muscle, but these factors are not restricted to muscle and 
seem to be important in a variety of tissues [105-107]. 
PGC-1α signaling 
Efficient mitochondrial turnover is essential for cellular homeostasis, and is 
accomplished by the continuous degradation of damaged mitochondria and biogenesis of 
healthy mitochondria. Damaged mitochondria can actively leak reactive oxygen species 
(ROS), causing significant oxidative stress and dysregulated energy production, potentially 
leading to cell death [108]. Degradation of mitochondria occurs through a selective form 
of macroautophagy known as mitophagy. Mitochondrial biogenesis is mainly regulated by 
peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) [109]. 
The AMPK-mediated increase in mitochondrial respiratory capacity has been shown to be 
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due to the activity of PGC-1α. AMPK induces PGC-1α expression and enhances its activity 
directly, through phosphorylation [110]. Additionally, the deacetylation of PGC-1α by 
SIRT1 has been shown to increase its transcriptional activity [111]. Mitochondrial 
turnover, also referred to as mitochondrial dynamics, involves the addition (fusion) or 
removal (fission) of mitochondria from the interconnected mitochondrial network. In 
human skeletal muscle, PGC-1α has been shown to regulate the expression of the 
mitochondrial fusion proteins, mitofusins -1 and -2 (MFN1 and MFN2), after a bout of 
exercise [112]. PGC-1α overexpression in vivo suggests that PGC-1α may also promote 
basal skeletal muscle autophagy and mitophagy [113]. Additionally, in PGC-1α knockout 
mice, stimuli-induced LC3-II conversion was significantly depressed vs control [114]. 
These data are suggestive that PGC-1α may actually have some regulatory control on 
overall mitochondrial quality, and not just mitochondrial biogenesis. 
Physiological Significance of Autophagy 
Autophagy is pivotal for proper cellular development, differentiation, survival, and 
homeostasis. All mammalian cells have an intrinsically active basal level of autophagy 
ongoing under normal conditions, functioning as a housekeeping process. The stimulation 
of autophagy, through stress-induced responses, acts as a survival mechanism to help 
ameliorate the disturbance. Not only is autophagy essential to the maintenance of 
homeostasis and the survival response of the cell, but it can also impact metabolism 
systemically. Interestingly, autophagy does not seem to have the same significance or stress 
response within each tissue, thereby giving autophagy tissue-specific effects and 
conditions [115]. Autophagy dysregulation, if left unchecked, can lead to the onset or 
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further progression of a number of pathologies, such as neurodegenerative, metabolic, 
muscular, infectious, or cardiovascular diseases [61, 62, 116, 117]. 
Metabolic diseases 
One of the most highly researched metabolic diseases is type II diabetes mellitus 
(T2D), which is typically an adult-onset form, although there are increasing levels of T2D 
seen in the younger population [118]. T2D develops from a chronic insulin resistant state 
and is characterized by hyperglycemia, hyperinsulinemia, and dyslipidemia [119, 120]. 
Many factors contribute to the development of insulin resistance and T2D, one of the 
primary factors of which is obesity [119, 121]. Obesity is characterized by an increase in 
the lipid storage of the visceral and subcutaneous adipose tissues, however there may also 
be a significant deposition of lipids in non-adipose tissues, that can mediate many adverse 
metabolic effects, most notably insulin resistance [122]. Increased lipolysis in adipose 
tissue results in of large amounts of FFAs and triglycerides in the systemic circulation [123, 
124].  
Excess lipid accumulation can be overwhelming for cells, causing dysfunction and 
death in non-adipose tissues, a process known as lipotoxicity [125, 126]. Of interest, 
autophagy dysregulation has been implicated in the pathophysiology of obesity, insulin 
resistance, and T2D [115]. Dysregulated autophagy, represented by excessive 
accumulation of autophagosomes, has been seen in the liver, pancreatic β-cells, adipose 
tissue, skeletal muscle, and immune cells of models for diet-induced obesity (DIO), insulin 
resistance, and T2D [127]. DIO models can vary by species used, macronutrient 
percentages in diet, and length of time for diet, but they typically all present with some 
form of insulin resistance [128]. A typical healthy cell can handle the frequent acute 
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fluctuations that occur in its nutrient supply due to a normal diet. However, with a chronic 
high-fat diet (HFD) for example, there is an abnormal shift in the lipid load that starts to 
cause severe dysfunction of key cellular metabolic pathways, such as autophagy. 
Skeletal muscles account for roughly 40-50% of total body mass, roughly 70-80% 
of whole-body insulin-stimulated glucose uptake, and a significant percentage of whole-
body fatty acid oxidation [102, 129, 130]. Consequently, many pathologies can arise when 
these features of skeletal muscle begin to deviate from their normal capabilities. In 
addition, autophagy has been shown to be critical for skeletal muscle homeostasis [131]. 
Since insulin stimulation inhibits autophagy, as previously described, it would be predicted 
that in insulin-resistant tissues, there would be elevated levels of autophagy. A high-fat diet 
has indeed been shown to induce insulin resistance, but it resulted in a reduction in basal 
autophagy in murine skeletal muscle, instead of an increase [132]. Mice that were fed a 
60% HFD for 12 weeks, developed dysfunctional skeletal and cardiac muscle autophagy 
vs their lean controls [132]. This was observed by a diminished LC3-II conversion and 
elevated p62 accumulation, suggestive that HFD-induced obesity could result in a 
dysfunctional stimuli-induced autophagy response. Similar findings were seen in a 48% 
HFD given for 6 weeks, which showed a marked decrease in LC3-II and increase in p62 
levels [133]. Though, with a mildly diminished fat content, a 12 week 45% HFD saw no 
change in LC3-II conversion, nor in LC3 or Beclin-1 mRNA levels, despite significant 
elevations in skeletal muscle lipid deposition [122]. This may suggest that a certain lipid 
load must be reached before autophagy dysregulation occurs. Though not a diet-induced 
model, another study did show that in the skeletal muscle of patients with insulin resistance 
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and T2D, there were reduced levels of autophagy-related genes, such as Atg14, 
GABARAPL1, and p62, and proteins, LC3-II, p62, and ATG5 [134].  
Dyslipidemia is an abnormal amount of lipids in the blood, and is often seen with 
obesity and T2D [120]. Dyslipidemia can induce an elevation in cell stress, inflammation, 
lipid and lipid intermediate accumulation, and insulin resistance [135, 136]. It was shown 
that when C2C12 myotubes were incubated for 72 hours in palmitate, a saturated fatty acid, 
autophagy was significantly diminished [133]. In obese patients with T2D, the 
normalization of plasma FFA levels does not correlate with improvement in their insulin 
sensitivity [137]. Although, a study investigating the effects of an intraperitoneal injection 
of FFAs (palmitate or oleate) on autophagy in the heart, liver, and skeletal muscle, showed 
that 2 hours of exposure to the FFAs caused a rapid autophagic response, characterized by 
LC3-II conversion, p62 degradation, and AMPKT172 phosphorylation [138]. This suggests 
that acute exposure to elevated FFA levels induces autophagy, potentially to remove excess 
lipid accumulation, whereas chronic exposure to elevated FFA levels dysregulates 
autophagy. However, further research is needed into the effects of a high-fat diet and/or 
elevated plasma FFA levels on skeletal muscle autophagy.  
In the liver, there seems to be a greater agreement on the effects of insulin-
resistance and autophagy. Mice that were fed a ~60% HFD, for only 8 weeks, showed a 
reduction in hepatic LC3-II/I ratio and increased p62 levels, compared to normal diet 
littermates, suggesting dysregulation of autophagy [139]. Similarly, another study showed 
that hepatic autophagy was reduced after 16 weeks of a 35.5% HFD [140]. This study saw 
a significant downregulation on the major autophagy proteins LC3, Beclin-1, Atg5, and 
Atg7. These results clearly show that, with high-fat diets, there seems to be a dysregulation 
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of autophagy that may contribute or be a result of insulin resistance. This down regulation 
of autophagy could have been through the overactivation of mTOR that is seen with obesity 
[141]. Not only does mTOR decrease autophagy, but it can also exacerbate the negative 
effects of insulin resistance by activating lipogenesis and decreasing fatty acid oxidation 
[142]. Another suspected mechanism suggested to be behind the dysregulated hepatic 
autophagy was a deficient fusion between autophagosomes and lysosomes, which can also 
be induced in vitro via pharmacological inhibitors of autophagy, such as bafilomycin A1 
(BafA1) or chloroquine (CQ) [75, 143].  
As stated earlier, there are tissue-specific effects of autophagy, and it seems that in 
adipose tissue it is the inhibition of autophagy that results in beneficial effects [144, 145]. 
Adipose tissue is very metabolically active and is an abundant site for insulin-stimulated 
glucose uptake [146]. There are two major types of adipose tissue in mammals, white 
adipose and brown adipose. White adipose tissue is a major depot for energy storage in the 
form of triglycerides and serves as an important regulator of the endocrine and immune 
systems [147]. Autophagy is essential for lipid storage and the differentiation of white 
adipocytes [145]. In Atg5 and Atg7 knockout mice, there were smaller white adipose tissue 
depots, suggesting that adipogenesis was impaired. During obesity, the excessive 
proliferation of white adipose tissue causes lipotoxicity and can lead to the development of 
T2D pathology [115]. Mathematical modeling and experimental data have shown that the 
expansion of adipose tissue seen in T2D can lead to the impairment of adipose tissue 
mTORC1 activation by insulin [148, 149]. This impairment would disinhibit autophagy 
and could be explain why it is elevated in adipose tissues. To further add to this impairment, 
the expansion of the adipose tissue is accompanied by inflammation, ER stress, and 
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hypoxic conditions, all of which can also inhibit mTORC1, thus promoting autophagy 
[150]. Brown adipose tissue, on the other hand, is a specialized tissue for energy 
expenditure and thermogenesis, that is primarily active in hibernating mammals and 
newborns [151]. Although this depot was thought to disappear over time in humans, it has 
now been shown to be preserved throughout adulthood [152, 153]. Interestingly, when 
autophagy is reduced in white adipocytes, some of these cells will actually develop brown 
adipocyte-like characteristics, in a process known as “browning” or “beiging” [154, 155]. 
White adipocytes have little mitochondria and are characterized by a single, large lipid 
droplet, while brown adipocytes have a lot of mitochondria and contain several small lipid 
droplets. Through adipose-specific Atg7 knockdown, newly formed beige cells show 
increased mitochondrial biogenesis, increased lipid droplet numbers, decreased lipid 
droplet size, elevated fatty acid oxidation, and increased insulin sensitivity [145]. 
Interestingly, in obesity-resistant mouse models, brown adipocytes are dispersed 
throughout white adipose depots and in skeletal muscle tissue too [156, 157]. Since brown 
and beige adipocytes have a high metabolic demand, they may be an extremely important 
therapeutic target for obesity and metabolic disorders [158].  
The fact that obesity and T2D is characterized by an increased resistance to and an 
increased secretion of insulin, the question remains of whether the elevated insulin levels 
could be the direct culprit in reducing autophagy levels or whether it is some unknown 
pathway that dysregulates autophagy. There are two widely used genetic mouse models for 
obesity, the ob/ob mice and the db/db mice. Both genetic models showed severely 
suppressed autophagy, but only one model presents with elevated levels of circulating 
insulin, the ob/ob mice. In the db/db mice, despite the low levels of circulating insulin, 
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these mice still showed lowered hepatic autophagy, with decreased Atg7, Beclin-1, Atg5, 
and LC3-II and increased p62 levels [140]. In skeletal muscle of db/db mice, there is 
reduced AMPK activation, Beclin-1 and Atg5 levels, and in the LC3-II/I ratio, as well as 
the complimentary increase in p62 levels [159]. This suggests that at least in the db/db 
model, high insulin is not the direct cause of autophagy dysregulation. Likewise, high 
insulin levels do not seem to be the cause of the dysregulated autophagy in the ob/ob mice. 
It was seen that the LC3-II/I ratio was reduced and p62 levels were elevated in ob/ob mice 
and when injected with streptozotocin, which is a chemical that is toxic to pancreatic β-
cells, there was no change to the suppressed hepatic autophagy levels [139]. Thus, it does 
not seem to be insulin-induced suppression of hepatic autophagy that is the culprit in this 
model. However, in skeletal muscle of ob/ob mice, there did not appear to be any changes 
in the levels of autophagy proteins when compared to their control littermate [122]. This 
variability between genetic models in skeletal muscle autophagy regulation could be due 
to the pathological differences between these two models [160]. 
Skeletal muscle diseases 
All skeletal muscles in the human body are a mixture of multiple cell (or fiber) 
types that differ in size, function, and metabolic characteristics. Most of these fibers are 
one of the following three: type I (mainly oxidative), type IIA (oxidative and glycolytic), 
or type IIB (mainly glycolytic). Mammalian muscles are actually composed of more than 
one fiber type [161]. Through external stimuli, skeletal muscle can grow (hypertrophy) or 
shrink (atrophy) in size due to changes in individual muscle fibers and not an increase or 
decrease in the number of fibers. Whether the muscle hypertrophies or atrophies can be 
thought of as a shift in the ratio of protein synthesis to degradation [162]. Since each fiber 
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type has its own unique metabolic characteristics, there exists differences in the basal and 
stimulated levels of autophagy for each fiber type [113, 163-165]. There is conflicting 
evidence on which fiber type shows greater autophagic activity. It might be that certain 
stimuli are fiber type-specific and depending on the stimuli used will depend on the fiber 
that has elevated or impaired autophagy.  
Though autophagy is essential for maintaining skeletal muscle homeostasis, 
autophagy may also contribute to pathogenesis. Some myopathies, such as forms of 
atrophy, present with elevated, uncontrolled autophagy that plays a role in, or is caused by, 
the pathogenesis [166]. Other myopathies, such as glycogen storage diseases and muscular 
dystrophies, have an abnormal reduction in autophagy that contributes to the disease [167]. 
Glycogen storage disease type II (GSDII), also known as Pompe disease, is a genetic 
disorder that is caused by the deficiency of a lysosomal enzyme that is responsible for the 
hydrolysis of glycogen to glucose, called acid α-glucosidase (GAA) [168]. Without this 
enzyme, glycogen accumulates in the lysosomes and there is an extensive buildup of 
autophagic cargo, leading to the clinical phenotypes of this disease [169, 170]. 
Additionally, the inhibition of autophagy in GSDII has been shown to induce myofiber 
atrophy, further implicating the necessity of proper autophagy function for skeletal muscle 
homeostasis [171]. In skeletal muscles, PGC-1α converts glycolytic fibers to oxidative 
fibers and may protect the muscle from atrophy [109]. In GAA-deficient muscles, the 
overexpression of PGC-1α resulted in a reduction of the autophagic buildup and an 
elevation in the expression of the autophagic markers, LC3-II/I, Beclin-1, and BNIP3 
[109]. SIRT1 has been shown to augment PGC-1α activity and thereby increase the supply 
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of new, healthy mitochondria [172]. SIRT1 may be important in regulating the removal of 
damaged mitochondria and the development of new mitochondria. 
Disuse or denervation of skeletal muscle results in its atrophy, which may be 
through transcriptional changes in key metabolic genes. The in vivo overexpression of the 
constitutively active form of FoxO3 causes myofiber atrophy through autophagy, and the 
FoxO3-mediated atrophy can be prevented by the inhibition of autophagy [103]. On the 
other hand, the overexpression of skeletal muscle PGC-1α reduced the FoxO3-dependent 
atrophy of fibers, at least partially by diminishing the relative expression levels of critical 
atrogenes, such as Atrogin-1, MuRF-1, and Cathepsin L [99]. When there is a significant 
reduction of basal levels of autophagy in skeletal muscle, the accumulation of proteins and 
organelles can be harmful to muscle homeostasis [173]. Atg7 null models show a 
significant deficiency in autophagic flux and profound skeletal muscle atrophy and muscle 
weakness [131, 174].  
Defective autophagy in skeletal muscle can also contribute to the pathogenesis of 
different types of muscular dystrophies. When autophagy is impaired, dystrophic muscles 
accumulate aggregated proteins and damaged organelles, but some of the structure and 
function of skeletal muscle can be restored by pharmacological reactivation of autophagy 
[175-177]. To the other extreme, excessively high levels of autophagy can be detrimental 
and contribute to skeletal muscle atrophy [176]. This shows the complexity of the 
autophagic pathway, as well as indicates a dual role for autophagy in maintaining skeletal 
muscle homeostasis [166]. Thus, it is vital for healthy skeletal muscle to maintain a proper 
balance of autophagic flux. Since proteolysis can be increased in some forms of muscular 
dystrophy, protease inhibitors are considered a potential therapeutic strategy [178]. 
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However, some data suggests that the benefits seen by inhibiting proteasomes in dystrophic 
mice are greatly outweighed by the deleterious effects of their continued inhibition [179]. 
This may be true also of autophagy, since both the UPS and autophagy function in 
proteolysis. However, recent findings suggest that autophagic dysregulation and the 
progression of dystrophy may not be dependent on one another, but instead, the autophagic 
buildup may be due to the decreased lysosomal biogenesis [180]. 
Additional autophagy-related diseases 
As mentioned previously, there are many other pathologies that are associated with 
autophagy dysregulation, such as neurodegeneration, infection, cardiovascular disease, 
cancer, and aging [181]. In neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, 
and Huntington’s disease, there is a very abundant accumulation of autophagosomes, 
suggesting the dysregulation of the autophagy pathway [182]. This autophagosome 
accumulation may not be a cause of these proteinopathies, per se, but an overload of the 
system that was attempting to clear the unwanted proteins. This is suggested by numerous 
studies showing that the upregulation of autophagic flux can clear misfolded and 
aggregated intracellular proteins, as well as protect against neurodegeneration [182-184]. 
Autophagy has now been shown to be essential in the development and 
pathogenesis of inflammation and immune responses [185]. The importance of autophagy 
in immunity is not limited to antigen presentation, but is also necessary for proper 
development, maintenance, and survival of inflammatory cells [186, 187]. The pro-
inflammatory cytokines and factors, type 1 interferons (IFNs), tumor necrosis factor alpha 
(TNF-α), interferon gamma (IFN-γ), interleukin 1 beta (IL-1β), and damage-associate 
molecular patterns (DAMPs), have all been shown to induce autophagy, whereas the anti-
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inflammatory cytokines IL-4, IL-10, and IL-13, inhibit autophagy [188, 189]. Additionally, 
autophagy can regulate the production and secretion of certain cytokines, including IL-1, 
IL-18, TNF-α, IL-1β and type I IFNs [190, 191]. Pattern recognition receptors (PRRs) are 
protein molecules present on several immune cells, that respond to invading pathogens. 
The cytosolic inflammasome complex, NLRP3, is a PRR that detects pathogen-associated 
molecular patterns (PAMPs) and elicit a pro-inflammatory cascade through caspase-1 
dependent maturation and secretion of IL-1β [192]. If not regulated properly, 
inflammasomes can induce severe tissue damage and potentially lead to the development 
of inflammatory diseases. Thus, the pathways that control inflammasome signaling are 
critical for the maintenance of healthy cells and tissues [192]. Autophagy has recently been 
shown to play a role in the inactivation of inflammasomes. Mice that are deficient in 
Atg16L1, the IL-1β maturation and secretion levels are greatly increased, suggestive of the 
activation of the inflammasome signaling pathway [193]. Thus, it seems that autophagy is 
an important constituent of many stages of immunity. 
 During cardiovascular stress, including heart failure and ischemia/reperfusion, 
autophagy is activated [194-196]. As it is in all tissues, autophagy is essential to 
maintaining a healthy cardiac cell [65]. Interestingly, this activation of autophagy might be 
harmful rather than helpful. After cardiovascular stress, the heart hypertrophies in 
response, and if the stress is chronic, then the hypertrophy becomes pathological and will 
be followed by heart failure [197]. It seems that autophagy may be regulating the 
progression of the structural remodeling in the heart that eventually leads to a pressure-
overloaded heart [198]. When autophagy proteins were overexpressed in cardiomyocytes, 
the pathological remodeling response was amplified, but when autophagy was inhibited, 
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there was a partial rescue from heart failure [198, 199]. However, when autophagy was 
completely blocked, through cardiac-specific deficiency of Atg5 in adult mice, this lead to 
cardiomyopathy, suggesting that there is still an essential protective role of autophagy in 
cardiomyocytes [200]. 
 Not only do normal, healthy cells require autophagy, but so do cancerous cells, 
more so even. Since a tumor cell is extremely metabolically active and quickly consumes 
the nutrients in its microenvironment, these cells must find other ways to maintain the 
essential metabolic machinery [201]. Indeed, in hypoxic tumor regions, autophagy is 
upregulated and is essential for the cells survival [202]. The functions of autophagy are in 
growth, survival, tumorigenesis, invasion, and metastasis of these cancer cells, potentially 
through suppression of p53 activation and/or its degradation [203-205].  Autophagy 
deficiency resulted in benign hepatomas, suggesting that autophagy is necessary for 
progression to malignancy and that autophagy inhibition could be a beneficial therapy 
[206]. However, similarly to chemotherapy and its negative off-target effects, systemic 
autophagy inhibition may have deleterious consequences in healthy tissues that require 
autophagy for homeostasis.  
 Aging has many physiological effects in the body and is associated with the 
development of a number of pathologies, such as neurodegenerative diseases, 
cardiovascular disease, cancer, arthritis, osteoporosis, diabetes, and muscle atrophy [207-
209]. With aging comes a progressive accumulation of damaged macromolecules and 
organelles, compromising cellular function [210]. This accumulation is one of the most 
consistent and persistent alterations to cells during the aging process, that results from the 
suppression of essential autophagic activity necessary to maintain cellular homeostasis 
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[211, 212]. The effect that aging has on autophagy has been ubiquitously shown in yeast, 
plants, and mammals [213-215]. By inducing the expression of single autophagy genes, 
the positive effects of longevity can be seen [216, 217]. Moreover, the loss-of-function of 
autophagy genes, that result in intracellular accumulation of damaged proteins and 
organelles, will significantly shorten the lifespan [218, 219]. Thus, autophagy is a potential 
therapeutic target for increasing longevity of organisms. 
Mediators of Autophagy 
Caloric-restriction 
The first evidence that calorie restriction, without malnutrition, could increase 
longevity and lifespan of mammals was revealed from a study on rats in 1935 [220]. 
Despite this extraordinary finding, another half a century would pass before the importance 
of this research would be further investigated. It has now been repeatedly demonstrated 
that calorie restriction can increase the lifespan in many models, such as yeast, worms, 
flies, rodents, and non-human primates [221, 222]. For example, in mice a 30-50% caloric 
restriction can increase the lifespan by 20-50% more than ad libitum feeding [223]. Caloric 
restriction has also been shown to delay the onset of diseases, such as cancer, diabetes, 
neurodegeneration, and cardiovascular disease [224]. Although longevity studies in 
humans is not practical, there has been research into longer-lived populations and what 
might be contributing to this. Though the effect of lifespan on humans is not yet observable, 
due to the long lifespan of humans, it has been shown that caloric restriction can increase 
overall health in humans by lower cholesterol, blood pressure, blood glucose, and plasma 
insulin levels [225].  
32 
 
Autophagy may mediate this increased lifespan and health through the cellular 
recycling of nutrients, removal of damaged organelles and proteins, and reduction of 
oxidative stress [226, 227]. During caloric restriction, there is a shift in metabolic activity 
away from an anabolic and toward a catabolic profile, preserving energy and nutrients for 
necessary processes [228]. Caloric restriction will decrease mTOR signaling and increase 
AMPK, SIRT1, and FoxO signaling [229]. As mentioned previously, mTOR and AMPK 
act on autophagy mainly through the regulation of ULK1. The role that AMPK plays in 
autophagy of skeletal muscle is exemplified by studies of AMPK knockout mice that have 
impaired autophagic signaling in response to starvation [230]. Additionally, AMPK can 
act on autophagy through SIRT1 and FoxO activity [231]. The activation of SIRT1 leads 
to the deacytelation of several key autophagy-related proteins such as Atg5, Atg7, LC3, 
and FoxO [71, 231, 232]. By overexpressing proteins, SIRT1 and SIRT6, several studies 
have shown that sirtuins are mediators of mammalian longevity [233, 234]. Similarly, to 
caloric restriction and autophagic induction, the overexpression of SIRT1 can mitigate 
diseases such as diabetes and neurodegeneration [235-237].  
Resveratrol is a natural compound, found in the skin of grapes, berries, and wine, 
that has similar therapeutic effects as caloric restriction, through the activation of AMPK 
and SIRT1 [238, 239]. The pharmacological activation of SIRT1 by resveratrol was shown 
to have health benefits in mice exposed to HFD, again potentially through autophagy 
regulation [238-240]. In SIRT1 knockout mice, the physiological benefits from resveratrol 
treatment and the augmented lifespan from caloric restriction are no longer seen, 
suggesting a direct involvement of SIRT1 in these processes [241, 242]. In addition to 
mediating the benefits of caloric restriction, it has been shown that caloric restriction can 
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actually induce the expression of several sirtuins, such as SIRT1, SIRT3, and SIRT5, thus 
propagating the benefits further [97, 243, 244]. Studies using AMPK KO mice show that 
AMPK is necessary for the activation of SIRT, and consequently caloric-restriction like 
benefits of resveratrol [245, 246]. Thus, the metabolic benefits of caloric restriction may 
be driven by regulation of autophagy, specifically through regulation of AMPK. 
Exercise 
An active lifestyle is one of the most effective ways to alleviate and prevent many 
pathological conditions, such as T2D, cardiovascular disease, neurodegeneration, and 
obesity [247]. Exercise positively regulates whole-body metabolism to provide these 
preventative and therapeutic benefits, similar to caloric restriction. Interestingly, even a 
single bout of physical activity can have metabolic benefits, though successive bouts 
provide greater effects. These effects are not localized, but systemic, effecting multiple 
tissues, such as skeletal muscle, liver, heart, pancreas, adipose tissue, retina, and brain 
[248]. Along with the positive effects of physical activity, the act itself is extremely 
stressful on the body and, depending on the intensity of the activity, may cause mechanical 
damage and acute inflammation in many tissues [249]. This acute stress is what allows, in 
part, the adaptation seen with exercise training. 
After exercise, a significant amount of remodeling occurs in skeletal muscle, 
including the synthesis of essential proteins, angiogenesis, and mitochondrial turnover, to 
name a few [248]. The maintenance of healthy mitochondria is of particular importance in 
functional skeletal muscle and, through the use of exercise training, can be greatly 
improved. Regulation of mitochondrial health works through two main mechanisms, 
mitochondrial biogenesis, which is the synthesis of new mitochondria, and mitophagy, 
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which is the autophagic removal of damaged or dysfunctional mitochondria [250]. 
Autophagy, including mitophagy, has recently been investigated as a mediator of the 
beneficial effects of exercise. In fact, a reduction in skeletal muscle autophagy can 
attenuate the improvements in aerobic endurance and glucose metabolism [113]. This 
suggests that functional autophagy is crucial for the physiological adaptations of exercise. 
As discussed with caloric restriction, exercise regulates a host of important 
metabolic proteins, some of which are AMPK, mTOR, sirtuins, FoxOs, and PGC-1α [251]. 
Each of these proteins can influence autophagy in some manner and depending on when 
the measurement is taken will greatly dictate which metabolic pathway will be activated. 
Acute exercise has been shown to immediately stimulate the catabolic pathway and inhibit 
the anabolic pathway, likely to preserve energy for contraction [252]. Immediately, there 
is increased pAMPKT172 and pACCS79, but no change in pmTORS2448 and pULK1S757, 
suggesting that autophagy initiation may immediately be upregulated [253]. Further 
evidence of this is seen in skeletal muscle-specific AMPK knockout mice that exhibited 
reduced exercise capacity, potentially through a reduction of autophagy initiation [230, 
254]. 
The release of Beclin-1 from Bcl-2 is now known to be necessary in order to have 
the stimulation of autophagy beyond basal levels [132]. This was discovered using a mouse 
model that replaced the three key phosphorylation sites on Bcl-2 (Thr69, Ser70, and Ser84) 
with alanine residues, generating the Bcl-2AAA mice. This mutation prevents the stimuli-
induced phosphorylation of Bcl2, preventing its dissociation from Beclin-1. These mice 
showed no alterations to their basal autophagic activity compared to wild-type mice, but 
did not show the exercise-induced increase in autophagy, due to Beclin-1 not dissociating 
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from Bcl-2 in this mutant mouse. In the skeletal muscle of wild-type mice, exercise caused 
an elevation in GFP-LC3 puncta, LC3-II conversion, and pAMPKT172 levels, as well as a 
reduction in p62 levels. However, in the skeletal muscle of Bcl-2AAA mice, there was no 
change in the levels of either LC3-II or p62 and it took a significantly greater amount of 
time in order to see any exercise-induced increase in pAMPKT172 levels. Further, the Bcl-
2AAA mice had decreased treadmill running distances and did not have an exercise-induced 
reduction in plasma glucose levels, compared to wild-type mice [132]. This data is highly 
suggestive that stimulated-autophagy is necessary for at least some of the acute beneficial 
effects of exercise. 
In order to rule out any other Bcl-2 functions and ensure that it was the defective 
autophagy that did not allow for exercise-induced improvements, another mouse model 
with a monoallelic loss of the gene encoding the Beclin-1 protein (Becn1+/-) was used 
[132]. In agreement, the Becn1+/- mice showed similar deficiencies in the exercise-induced 
increase of autophagy in skeletal muscle. As well, these mice, when compared to wild-
type, showed decreased muscle strength, treadmill running distance, GLUT4 plasma 
membrane localization, muscle glucose uptake, and pAMPKT172 levels [132]. This suggests 
that it is, in fact, the defective autophagy that is preventing the exercise-induced 
improvements to endurance and glucose uptake, and AMPK activation seen in the Bcl-
2AAA mice. This observation in Becn1+/- mice was repeated and verified by another lab 
[113]. The fact that a lack of AMPK activation coincides with defective autophagy and 
defective exercise-induced benefits may suggest that AMPK is not only a regulator of 
autophagy, but is regulated by autophagy in a feed-forward manner. To investigate this, a 
mice model with reduced expression of Atg16L1 (Atg16L1HM), a protein that is essential 
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for the formation of autophagosomes, was used [132]. This model too showed a skeletal 
muscle defect in the exercise-induced autophagy response. Yet again, these data suggest 
that autophagy function is, at least partially, required for the appropriate AMPK activation 
from exercise. 
To further characterize the necessity of autophagy in the metabolic effects of 
exercise, wild-type and Bcl-2AAA mice underwent a 60% HFD for four weeks, then an 
additional 8 weeks with or without 50 minutes of daily treadmill exercise [132]. 
Interestingly, Bcl-2AAA mice were more sensitive to HFD-induced obesity. Even more 
interesting, is that Bcl-2AAA mice showed a similar reduction in magnitude of weight gain 
with 8 weeks of exercise as did the wild-type mice. So, there was no alteration in the ability 
of exercise to reduce the impact of HFD-induce obesity. However, despite the similar 
reduction of weight gain, the Bcl-2AAA mice did not have the same improvement in glucose 
tolerance as the wild-type mice did after HFD and exercise [132].  Although this was not 
repeated in the other mutant mouse models (such as the Becn1+/- and Atg16L1HM mice), 
this data suggests that exercise-induced autophagy is necessary for improvement in the 
glucose intolerance from a HFD. 
Heat 
Changes in climate could not only have environmental implications, but also 
implications on public health and animal production [255, 256]. Most cells and organisms 
have a fairly narrow temperature range in which they function well, and any deviation from 
that homeostatic range causes stress. An acute, mild stress can aid in survival by allowing 
organisms to adapt to the rapidly and constantly changing environment. This adaptation 
response to acute stress is referred to as a hormetic response [257]. Heat is one of the many 
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stressors that has this hormesis effect. For simplification and the purpose of this review, 
heat stress will be used to refer to the negative effects of heat, while heat treatment will be 
used to refer to the positive effects of heat. 
All living organisms respond to elevated temperatures by inducing the expression 
of stress-response proteins, a subset of these are called heat shock proteins (HSPs) [258]. 
HSPs are considered to be the main drivers of the beneficial effects of heat treatment, likely 
due to their very robust response to heat [259, 260]. These proteins are a prime 
consideration of the therapeutic benefits of heat treatment and the reduction of HSP 
expression may partially explain the increased risk of heat-induced illnesses or injuries 
seen with age, disease, and obesity [261, 262]. HSPs are molecular chaperones that exist 
in very high basal concentrations in cells, and can be induced further by stress, to sustain 
intracellular protein homeostasis [263]. There are 5 major HSP families that are 
characterized by their molecular weights: HSP100, HSP90, HSP70, HSP40, and small 
HSPs (Table 1) [264]. Despite the specificity of the name given to these proteins, many 
stressors have been shown to induce their expression, such as oxidative stress, hypoxia, 
exercise, and caloric restriction [265-267]. The regulation of HSP expression is primarily 
through the activation and function of heat shock factor 1 (HSF1) [268]. Upon activation, 














Table 1. Heat shock protein (HSP) families and their functions. 
 
Heat stress 
Regarding heat stress (HS) in humans, excess temperature can cause heat stroke, 
heat exhaustion, heat syncope, and heat cramps. A healthy individual has the regulatory 
mechanisms to handle elevated temperatures, at least to a point. However, there is a much 
greater risk for heat-induced illnesses and injuries for the elderly population and 
individuals with conditions such as cardiovascular disease, diabetes, and/or obesity [269]. 
In the agricultural production industry, a primary concern is the reduction in the overall 
yield, since excess HS can cause severe damage in plants and animals, such as atrophy of 
skeletal muscle. For example, in porcine skeletal muscle, 12 hours of HS increased 
inflammatory signaling and oxidative stress [256]. It has also been shown that similar 
chronic heat stress causes a dysregulation in the autophagic machinery [165, 270]. 
However, cells have numerous stress response pathways that become activated to help 
maintain homeostasis. For example, when cells are exposed to heat, then the heat shock 
response (HSR) is activated, inducing the expression of vital HSPs to protect and repair 
the cell. The negative effects from heat are due to an increased heat load, which involves 
factors such as time, temperature, and humidity, that goes beyond what the organism can 
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easily tolerate. If this load is lessened to a great enough degree, then the effects are 
extremely different.  
Though the HSR is a widely acknowledged cellular event that occurs upon the 
exposure of mammalian cells to heat, some research has shown that porcine skeletal muscle 
showed no alterations in Hsp70 or Hsp90 expression [256]. This is in stark contrast to the 
majority of the research on the effects of heat on the HSR and is likely due to differences 
in the study design. This study housed gilts in either a thermoneutral (TN) condition (21°C 
with 70% humidity) or heat stress (HS) condition (37°C with 40% humidity), with various 
durations of heating: 2hr HS, 4hr HS, and 6hr HS [271]. From the results of this study, the 
authors showed that all durations of HS caused no changes in skeletal muscle Hsp70 or 
Hsp90 expression from that of TN [256]. This is extremely interesting, since Hsp70 is 
considered the most heat-inducible HSP, and many studies have corroborated this fact 
[259, 272-274]. The difference in humidity for the TN and HS pigs is an interesting aspect 
that may have been overlooked by the investigators. The relatively high humidity level of 
70% for the TN pigs, that was lowered to 40% for the HS pigs, could have increased the 
heat load for the TN pigs. If this were true, then it may be that the confounding results were 
due to elevated HSP expression in the TN pigs, that was not further elevated by the short 
durations of HS. Additionally, though the core temperature increased in HS pigs, the 
skeletal muscle temperature (which was not measured) may not have increased enough to 
necessitate the activation of the HSR. However, the skeletal muscle tissue showed an 
apparent elevation of skeletal muscle inflammatory signaling markers, despite the lack of 
HSP expression [256]. However, the HS may not have been the direct cause of this 
inflammatory signaling upregulation in skeletal muscle. The influence of extracellular 
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stimuli, such as hormones, nutrients, or cytokines, as the direct cause of the increased 
inflammatory markers in the skeletal muscle tissue cannot be ruled out. 
Heat treatment 
Heat treatment (also referred to as mild heat stress, therapeutic hyperthermia, heat 
therapy) involves a mild, yet still stressful, bout of heating over a short period of time, 
usually 1 hour or less. The method of applying the heat can vary greatly and will ultimately 
dictate what physiological effects will occur. For localized heat treatment, some common 
methods use pads, wraps, or other small heating devices. This review will only focus on 
systemic heat treatment, which can be performed using heat chambers, heated baths, or 
steam rooms. This form of heating will cause a rise in core body temperature, increased 
heart rate, and elevated blood flow, all of which will aid in the beneficial effects seen, 
including the attenuation of muscle atrophy, improvement of insulin sensitivity, and 
cardiovascular health [259, 275, 276]. Interestingly, some similar beneficial effects are 
seen with exercise as with heat treatment, and exercising muscles can have temperature 
values between 36-44°C, depending on the intensity of exercise [277, 278]. The heat 
generated from the exercising muscles must be transferred to cooler areas of the body, 
primarily via the blood. Only ~30% of the chemical energy from ATP is converted to  
mechanical energy for contraction, so ~70% is lost as heat, causing an elevation of the 
tissue and core temperature [279]. So, the beneficial effects of exercise could, at least in 
part, be due to elevated body temperatures. 
A seminal report from Dr. Phillip L. Hooper, was one of the first to demonstrate 
that heat treatment could be used to provide therapeutic metabolic benefits [280]. To 
investigate this, eight patients with T2D were immersed in 37.8°C-41.0°C water at 
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shoulder height for 30 minutes a day, six days a week, for three weeks. The oral 
temperature rose an average of 0.8°C during each session and after three weeks, there was 
a reduction in mean weight, fasting plasma glucose levels, and hemoglobin A1c levels. To 
add to these measurable health benefits, the patients reported improved sleep quality and 
an increased overall sense of well-being [280]. These findings led the authors to suggest 
that heat treatment should be further evaluated as a therapeutic option for patients with 
T2D, especially for those whom exercise is not a possibility or too great a risk. Using a 
similar model for the application of heat, a study showed that the lower body immersion 
of HFD-fed rats only once per week, for 12 weeks, resulted in protection against DIO 
related complications, such as hyperglycemia, hyperinsulinemia, glucose intolerance, and 
insulin resistance [259]. Additionally, it has been shown that the use of a heat chamber can 
provide similar benefits [260]. Thus, it has now been repeatedly shown that heat treatment 
is a valid tool to improve insulin resistance and T2D. 
Of the HSP family members, Hsp70 (also known as Hsp70i, Hsp72, and HSPA1A) 
and the small HSP (sHSP) Hsp27 (also known as HSPB1 or Hsp25 in murines) are among 
the most inducible HSPs and are typically considered key factors influencing the heat-
induced cellular protection and/or benefits. For simplicity, I will refer to them as Hsp70 
and Hsp27, regardless of the model. As previously mentioned, some of the benefits of 
exercise could be due to the elevation in body or tissue temperature. It has been shown that 
exercise training, or even a single bout of exercise, can induce the expression of Hsp70 
[281, 282]. Interestingly, rats given a single, submaximal exercise bout, either in a cool or 
heated environment, exhibited differences in their core body temperature (Tc) that was 
correlated to the observed differences in expression levels of skeletal muscle Hsp70 [283]. 
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Rats were placed into one of four groups: cool (Tc < 38°C) ± exercise or heat (Tc = 41°C) 
± exercise [283]. With no difference in the duration of exercise or the time to reach a Tc of 
41°C, the results demonstrated that Hsp70 expression was significantly reduced after 
exercise when the Tc was not allowed to rise to 41°C in both skeletal and cardiac muscles 
[283]. In rats that received exercise training for 3, 6, or 9 weeks in a 23°C room or in a 4-
8°C environment, similar findings were observed [284]. In this study, Tc was measured 
after the last exercise bout and were ~38°C for rats exercised in the cold and ~40.5°C for 
the rats exercised at room temperature [284]. For rats exercised in the cold, there was no 
change compared to the sedentary controls, and an obvious attenuation of myocardial 
Hsp70 expression versus rats exercised in room temperature [284]. Additionally, more 
recent research corroborates these findings in myocardial, skeletal muscle, and liver tissue, 
as well as showing that extracellular Hsp70 (eHsp70) expression, which is suggested to 
function as an immune signaling molecule, was also attenuated when the exercise-induced 
elevation in Tc was prevented  [285]. These studies and their findings suggest that elevation 
of the core body temperature may play a large role in the physiological benefits of exercise. 
When Hsp72 was overexpressed in HFD-fed mice, just as with heat treatment, there 
were significant improvements in glucose tolerance and insulin sensitivity, suggesting that 
Hsp72 plays a key role in providing the heat-induced benefits [260]. In the skeletal muscle 
of a streptozotocin-induced diabetic rat model, the expression levels of Hsp72 and the small 
HSP, Hsp25 (Hsp27 in humans), were not reduced basally due to diabetes [286]. However, 
after rectal temperature was raised to 42.0°C for 15 minutes, Hsp72 was increased greater 
than in control rats, while the heat-induced elevation in Hsp25 and HSF1 was absent in the 
streptozotocin rats [286]. The skeletal muscle of a DIO rat model showed that 12 weeks of 
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a once per week 20 minute 41°C-41.5°C heat treatment could attenuate the HFD-induced 
increase of JNK and IKK-β activation, potentially through the induction of Hsp72 
expression and pHsp25S82 [259]. The activation of the stress-induced kinases, JNK and 
IKK-β, can cause the inhibition of insulin signaling, leading to insulin resistance. In the rat 
skeletal muscle, L6, cell line, an acute bout of heat treatment lead to the increase in fatty 
acid oxidation and mitochondrial oxygen consumption [259]. In agreement, a study using 
C2C12 cells, showed that a single bout of a 1 hour 40°C heat treatment did not elevate 
Hsp72 protein levels until 24 hours after the heating session [272]. Although the Hsp72 
protein levels were not elevated immediately after heating, the relative mRNA associated 
with Hsp72 (Hspa1a and Hspa1b) was significantly increased at 2 and 24 hours, but less 
so at the 24 hour timepoint. Also, pAMPKT172 was elevated immediately, but not after 24 
hours of recovery, while SIRT1 was elevated after 24 hours of recovery, but not 
immediately [272]. When these cells were then exposed to repeated bouts of 1 hour 40°C 
heat treatment, there was an elevation of PGC-1α, oxidative phosphorylation subunits, and 
mitochondrial biogenesis [272]. This expresses that other events are occurring 
simultaneous to the HSP-specific changes that could be inducing the metabolic benefits. 
Heat and autophagy 
Proper protein folding and degradation are essential in maintaining protein quality 
control that is essential for intracellular homeostasis. This control works through a 
cooperation of signaling pathways that include HSPs, the UPS, and autophagy [61]. These 
pathways that make up the network of protein homeostatic control likely do not work 
independently, but may communicate and regulate one another through a variety of 
mechanisms [287]. One study showed that in a host of different cell lines (including HeLa, 
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human embryonic kidney 293T, human breast cancer MCF7, mouse neuroblastoma N2a, 
murine melanoma B16, human lung adenocarcinoma A549, and human neuroblastoma SH-
SY5Y cells), 30 minutes of 43°C heating was enough to induce autophagy [288]. This 
study saw concurrent increases in HSP and LC3-II expression, as well as GFP-LC3 puncta 
accumulation, with heating. This suggests that these two pathways may work together to 
help prevent stress-induced intracellular damage. Additionally, this study investigated the 
effects of transfecting cells with a constitutively active form of HSF1. Interestingly, in 
HSF1(+) cells, Hsp70 and Hsp27 expression was elevated, but there was a reduction in 
LC3-II formation [288]. When heat was applied to the HSF1(+) cells, the heat-induced 
LC3-II formation was diminished compared to control cells. Furthermore, the siRNA 
knockdown of HSF-1 protein expression in human lung epithelial carcinoma A549 cells 
resulted in elevated LC3-II formation, that could be attenuated by the overexpression of 
Hsp70 in these cells [287]. Although some may conclude that this suggests that autophagy 
is under tight control of HSF1 and/or the HSP network, it merely suggests that when the 
heat shock system is abundantly active, there may not be as great a necessity for autophagic 
activity. 
Another way in which HSPs can interact with autophagy is through chaperone-
mediated autophagy (CMA), which involves the chaperone-mediated delivery of cytosolic 
proteins to lysosomes for their degradation. In particular, Hsp70 recognizes a specific 
amino acid sequence on intracellular proteins and, with assistance from co-chaperones 
(Bag1, Hip, Hop, and Hsp40), delivers the proteins to the lysosome [289]. After this 
recognition step, Hsp70 will dock at the lysosomal membrane through its interaction with 
the lysosome-associated membrane protein type 2A (LAMP-2A) receptor [290]. The 
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chaperone-substrate complex is not enveloped by the lysosomal membrane, but instead, 
the chaperone and co-chaperone system first unfold the substrate and then it can be 
internalized through the LAMP-2A receptor [291]. Interestingly there is also a luminal 
form of Hsp70 that is in the lysosome and is necessary for substrate translocation [292]. 
Once internalized, the substrate is quickly degraded by lysosomal hydrolases. Around 30% 
of cytosolic proteins are thought to be potential substrates for CMA and around 40% of 
lysosomes are thought to be competent for the uptake of CMA substrates [293, 294]. 
However, the percentage of lysosomes can escalate to ~80% upon induction of CMA, 
through the increased transcription of LAMP-2A by mechanisms such as starvation or 
oxidative stress [295]. It seems that there is communication and coordination between 
CMA and macroautophagy. In immortalized mouse embryonic fibroblast (MEF) cells 
derived from Atg5-/- mice, the deficiency in macroautophagy caused an elevation in basal 
and starvation-induced CMA levels [296]. This elevation in CMA activity, seen by 
elevations in LAMP-2A and Hsp70 colocalization and expression, was also seen when 
normal MEFs were incubated with the macroautophagy inhibitor (specifically a PI3K 
inhibitor), 3-Methyladenine (3-MA) [296]. Conversely, LAMP-2A(-) MEFs, where CMA 
is inhibited, LC3-II expression was elevated under basal and starvation conditions [297]. 
This shows the adaptability that cells have in regulating intracellular homeostasis. When 
one system is malfunctional, another system can compensate.  
Autophagy may not be directly regulated by HSPs. HSF1 can induce the expression 
of non-HSP, stress-response genes, such as IL-1β, TNF-α, c-fos, and P-glycoprotein [298-
301]. TNF-α has been shown to induce the activation of autophagy through NF-κB activity 
[302]. In HeLa cells, a bout of heat at 43°C for 90 minutes resulted in increased Hsp72, 
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Hsp27, and LC3-II expression, as well as increased GFP-LC3 puncta [303]. When the Hela 
cells were first treated with a p65-shRNA to knockdown p65 (transcriptional subunit of 
NF-κB) expression, the impact of heating increased the HSPs expression as in control, but 
the heat-induced increase in LC3-II expression and GFP-LC3 puncta formation was greatly 
diminished. Thus, other factors may strongly contribute to the activation and regulation of 
autophagy, other than HSP-related activity of HSF1.  
Summary and Concluding Remarks 
 The regulation of autophagy is an essential component of metabolic health. Heat 
treatment-induced elevations of autophagy could be a useful therapeutic method, that 
warrants further investigation. The majority of the research into heat stress and heat 
treatment involves the HSR and the inducible-HSPs. Due to the significant role that skeletal 
muscle plays in the systemic metabolic regulation, and the role that autophagy plays within 
skeletal muscle, the impact of heat treatment on skeletal muscle autophagy is in need of 
investigation. Understanding the mechanisms that govern the beneficial effects of heat, 
might allow for more efficient therapies to be developed for a variety of autophagy-related 
pathologies. In addition, heat treatment could prove to be a valuable therapy for these 
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Abstract 
Autophagy is a major intracellular degradation process that is essential for the 
clearance of unnecessary proteins/organelles and the maintenance of cellular homeostasis. 
The inhibition of autophagy has been shown to have severe cellular consequences that are 
correlated with many skeletal muscle pathologies. In nearly all mammalian cells, 
autophagic activity tends to decrease with age, potentially priming the cells for various 
pathological conditions, such as neurodegeneration or insulin resistance. Thus, finding 
methods that can elevate autophagic activity may provide invaluable protection from such 
pathologies. Acute exposure to low heat loads (heat treatment) has been shown to have 
therapeutic effects, however the impact of heat on autophagy signaling remains unclear. 
C2C12 myotubes were maintained at 37°C (thermoneutral; TN) or heated at 40°C (heat 
treatment; HT) for 1 or 2 hours. Myotubes were harvested immediately (0hr) after heating, 
or returned to 37°C for recovery of 2 hours (2hr) or 24 hours (24hr). For an indication of 
autophagic flux, a subset of the samples received 3 hours of BafA1 treatment. HT for 1 and 
2 hours resulted in an elevation in pAMPK (T172) and pULK1 (S555), suggesting an 
increase in the initiation of autophagy. The expression of LC3 II, a marker for 
autophagosome formation, was also elevated in myotubes exposed to both heat durations. 
With 2 hours of heating, there was a significant elevation of cell stress markers, such as p-
p38 (Thr180/Tyr182), pJNK (Thr183/Tyr185), and pNFκB (Ser536), that was not seen 
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with 1 hour of HT. These findings suggest that acute, low heat loads may be beneficial to 
skeletal muscle by reducing expression levels of cell stress proteins. This may be 
accomplished through the induction of two pro-survival pathways, autophagy and the heat 
shock response. 
Introduction 
Macroautophagy, herein referred to as autophagy, is an essential and highly 
regulated mechanism for the bulk degradation of cytosolic proteins and organelles in 
mammalian cells. While the basal levels of autophagy might be tissue- or cell type-
dependent, the induction of autophagy by stress is highly conserved [1]. Hypoxia, oxidative 
stress, nutrient depletion, and exercise are just some of the many stressors that have been 
shown to increase autophagic activity [2]. This increase in autophagy serves as an adaptive 
response mechanism, essential for the cell’s survival and return to homeostasis. 
Skeletal muscle is a highly dynamic and plastic tissue, which are vital for 
maintaining skeletal muscle homeostasis, since this tissue depot is constantly experiencing 
physical and metabolic stress due to contraction [3]. Due to the necessity for skeletal 
muscle protein turnover, this tissue has high rates of protein synthesis and degradation [4]. 
There are three main systems that contribute to skeletal muscle protein degradation, the 
ubiquitin-proteosomal system (UPS), the calpain Ca2+-dependent cysteine proteases, and 
autophagy [5]. Muscular contraction during exercise induces a state of metabolic stress in 
skeletal muscle, decreasing ATP content, altering molecular messengers, and inducing 
protein and organelle damage [3]. These effects are all known inducers of skeletal muscle 
autophagy and likely play a major role in its upregulation in skeletal muscle during exercise 
[6]. An additional effect of muscular contraction during exercise is the elevation of core 
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body and skeletal muscle temperatures [7]. The elevation of cellular temperature induces 
many specific cell stress responses, likely the most notorious is the heat shock response 
(HSR). Interestingly, autophagy and the heat shock response are closely intertwined on 
many different levels and have even been shown to regulate each other [8]. While there is 
literature supporting the adverse effects of prolonged heating on skeletal muscle 
autophagy, less is known about the effects of acute heating on autophagy signaling in 
skeletal muscle [9]. 
The purpose of the present study was to investigate the effects of an acute bout of 
differing HT durations on autophagic signaling in skeletal muscle cells. To do this, we 
exposed C2C12 myotubes to 1 hour or 2 hours of HT at 40°C, with and without recovery. 
We hypothesized that a single bout of HT, regardless of the duration, would increase 
autophagic signaling in skeletal muscle cells, which would increase the overall flux. 
Materials and Methods 
Materials 
C2C12 myoblasts (CRL-1772) were purchased from ATCC (Manassas, VA). Dulbecco's 
Modified Eagle's medium (DMEM), Penicillin-Streptomycin (P/S), fetal bovine serum 
(FBS), and horse serum (HS) were purchased from Invitrogen (Grand Island, NY). L-
Glutamine was purchased from ThermoFisher Scientific (Carlsbad, CA). Bafilomycin A1 
(BafA1) was purchased from Tocris Bioscience (Minneapolis, MN). 
Cell culture 
C2C12 myoblasts were cultured at 37°C, with 5% CO2, in complete growth medium, 
containing normal glucose (5.5 mM) DMEM supplemented with 10% FBS, 1% L-
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Glutamine, and 1% P/S. Growth media was replenished every 24-48 hours and cells were 
passaged upon reaching 70-90% confluency. Once at 70-90% confluency, myoblasts were 
differentiated into myotubes by the replacement of growth media with differentiation 
media, containing normal glucose (5.5 mM) DMEM supplemented with 2% HS and 1% 
P/S. Differentiation was performed for 5 days, with the media being replenished every 24-
48 hours. On day 5 of differentiation, the medium was changed to serum-free medium, 
containing normal glucose (5.5 mM) DMEM supplemented with 1% P/S. 
Treatment of cells 
A representation of the study design is given for heat treatment (HT), BafA1 treatment, 
recovery (0h, 2h, or 24h), and harvesting times (Figure 1). Myotubes were either 
maintained at 37°C or given a single bout of 40°C HT for 1 or 2 hours, by placing the 
cultures into an incubator at 40°C, with recovery times of 0, 2, and 24 hours at 37°C. For 
an indication of autophagic flux, some cells were treated with BafA1 (100 nM), 3 hours 
prior to cell harvesting. 
Cell lysate preparation 
Upon completion of the treatment protocol, the serum-free media was removed and cells 
were washed twice on ice with phosphate buffered saline (PBS). Cells were then lysed with 
1X cell lysis buffer (Cell Signaling; Danvers, MA), containing 1X Halt Protease Inhibitor 
Cocktail (ThermoFisher Scientific; Waltham, MA) and 1X Phosphatase Inhibitor Cocktail 
3 (MilliporeSigma; Burlington, MA), and removed from wells using a sterile, double-
ended cell lifter (CellTreat Scientific Products; Pepperell, MA). Cellular debris was 
removed from lysates by centrifugation at ~20,000g for 15 minutes at 4°C, and the 
supernatant was removed and stored at -80°C until analysis. Protein concentrations were 
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assessed using the Pierce BCA Protein Assay Kit (ThermoFisher Scientific; Waltham, 
MA).  
Western blot analysis 
Samples were then prepared for western blot analysis by denaturation in Laemmli sample 
buffer (Bio-Rad; Hercules, CA), containing the reducing agent dithiothreitol (DTT), at 
95°C for 5-10 minutes. The prepared samples were equally loaded into 4-15%, 4-20%, or 
8-16% Stain-Free Criterion TGX gels (Bio-Rad) to final protein amounts of 5-30 µg, per 
lane. After electrophoresis was complete, proteins were transferred to PVDF membranes 
(MilliporeSigma). To ensure proper electrophoresis and transfer of proteins, as well as 
obtain a precise measurement of total lane protein, membranes were subjected to Bio-Rad’s 
Stain-Free protocol to obtain an image of total lane protein [10]. Protein-coated membranes 
were then blocked, in 5% fat-free milk in Tris-buffered saline containing 0.1% Tween-20 
(TBS-T), for 1 hour at room temperature. After blocking, membranes were cut and probed 
with primary antibodies (1°) overnight at 4°C. Following 1° incubation, membranes were 
probed with HRP-linked anti-rabbit or anti-mouse secondary antibodies (Cell Signaling), 
at a concentration of 1:2000-1:5000, for 1 hour at room temperature. Western blot images 
were captured with the ChemiDoc™ XRS Imaging System (Bio-Rad), and images were 
analyzed using Image Lab™ 6.0 Software (Bio-Rad). The primary antibodies specific for 
AMPKα (#2532), phospho-AMPKαT172 (#2531), Atg3 (#3415), Atg16L1 (#8089), IκBα 
(#4814), phospho-JNKT183/Y185 (#4668), LC3A/B (#12741), mTOR (#2983), phospho-
mTORS2448 (#2971), phospho-NFκBS536 (#3033), PI3K Class III (#4623), p38 (#9212), 
phospho-p38T180/Y182 (#9211), phospho-ULK1S757 (#6888), and phospho-ULK1S555 
(#5869), as well as the secondary horseradish peroxidase (HRP)-linked antibodies (#7074, 
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#7076) were purchased from Cell Signaling Technology. Antibodies specific for αC-
crystallin (sc-398395), Beclin-1 (sc-48341), p62 (sc-28359), HSF1 (sc-17757), Hsp27 (sc-
13132), phospho-Hsp27S82 (sc-166693), and Hsp70 (sc-24) were obtained from Santa Cruz 
Biotechnology, Inc. (Dallas, TX). 
Statistics 
Data are presented as mean ± SEM. Statistical differences between groups were analyzed 
using a One-Way or Two-Way ANOVA. When appropriate, this was followed by a post 
hoc comparison using the Tukey test. Statistical significance was set to p < 0.05. 
Results 
A single bout of 1 hour 40°C heat treatment (HT) induces autophagy signaling. We 
examined the effect of HT on skeletal muscle autophagy in C2C12 myotubes. Autophagy 
can be broken down into four general stages: initiation, vesicle formation, fusion, and 
degradation (Figure 2A). Analysis of mTOR activation after 1 hour of 40°C HT, through 
the levels of phosphorylation at Ser2448, showed no significant changes (Figure 2B). 
Whereas, the phosphorylation of AMPK at Thr172, which is required for AMPK 
activation, was significantly elevated at 0hr recovery, compared to TN (p = 0.0023), 2hr 
recovery (p = 0.0035), and 24hr recovery (p = 0.0233) (Figure 2C).  
The main protein involved in autophagy initiation, ULK1, is regulated by many 
phosphorylation sites, but two main sites are: Ser757 (phosphorylated by mTOR to inhibit 
autophagy) and Ser555 (phosphorylated by AMPK to activate autophagy). The 
phosphorylation of ULK1 at Ser757 showed a trend to decrease with the 0hr recovery (p = 
0.0597) group compared to TN, while ULK1 phosphorylation at Ser555 was significantly 
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elevated at 0hr recovery (p = 0.0125) compared to TN (Figure 2D and 2E). There was a 
significant elevation in LC3 II levels with 2hr recovery compared to TN (p = 0.0100) and 
24hr recovery (p = 0.0454) (Figure 2F). However, HT did not have any effect on the levels 
of p62 (Figure 2G). The inhibition of autophagy by the addition of BafA1 lead to a 
significant increase in both LC3 II (p < 0.0001) and p62 (p < 0.0001) levels, compared to 
control (Figure 2F and 2G). Interestingly, in BafA1 treated cells there was a significant 
reduction in LC3 II levels in the 0hr (p = 0.0107) and 2hr (p = 0.0474) recovery compared 
to TN (Figure 2F). There was only a main effect with BafA1 treatment for p62 (p < 0.0001), 
while LC3 II had a main effect of BafA1 treatment (p < 0.0001), a trend for a main effect 
in HT (p = 0.0646), and a significant interaction effect (p < 0.0001). 
Regulation of key autophagy proteins by 1 hour 40°C HT. Autophagy is a very complex 
pathway with a large variety of proteins that are involved in its activity. We further 
examined several key autophagy proteins that vital to the process at different stages. Unlike 
the alterations seen in the initiation and autophagosome markers, Atg3, Atg16L1, and PI3K 
Class III expressions did not change with HT (Figure 3A-C). However, there was a 
significant increase in Beclin-1 expression at 2hr (p = 0.0016) and 24hr (p = 0.0009) 
recovery, compared to TN (Figure 3D).  
1 hour 40°C HT activates the heat shock response. Upon its activation, HSF1 becomes 
hyperphosphorylated, trimerizes, and relocates to the nucleus for transcriptional activation 
of key heat shock proteins (Figure 4A). The hyperphosphorylation of HSF1 causes a shift 
in the appearance of the protein band’s molecular weight, when analyzed by SDS-PAGE 
and Western blot. To obtain a quantification of the shift in HSF1, images were analyzed 
for two bands, and are expressed as a fold-shift in the hyperphosphorylation to 
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normophosphorylation ratio (Figure 4B). When examined, HSF1 was significantly 
hyperphosphorylated at 0hr recovery compared to TN (p < 0.0001), 2hr recovery (p < 
0.0001), and 24hr recovery (p < 0.0001) (Figure 4B). Heat causes an elevation in Hsp70 
levels and an elevation of phosphorylated Hsp27 at Ser82. Hsp70 expression was 
significantly elevated by HT at 0hr (p = 0.0081), 2hr (p = 0.0017), and 24hr (p = 0.0007) 
recovery, compared to TN (Figure 4C). The phosphorylation of the small heat shock 
protein, Hsp27, at Ser82 was significantly reduced at 0hr recovery (p = 0.0194) compared 
to TN (Figure 4D). However, the levels of phosphorylated Hsp27 significantly increased 
at 24hr recovery (p = 0.0089), compared to 0hr recovery (Figure 4D). The total Hsp27 
protein levels did not change significantly with HT (p > 0.1). Investigation of another small 
heat shock protein, αC-crystallin, showed a similar pattern as Hsp70, but was not 
significantly altered by HT (Figure 4E). 
Regulation of cell stress markers after heating for 1 hour at 40°C. We further examined 
any negative effects of 1 hour 40°C HT, by analyzing the expression levels of several cell 
stress markers. The phosphorylation of the MAP kinase, p38, at Thr180/Tyr182, was 
significantly reduced by HT at 0hr (p = 0.0096) and 2hr (p = 0.0009) recovery compared 
to TN, and significantly elevated at 24hr recovery (p = 0.0052) compared to 2hr recovery 
(Figure 5A). The phosphorylation of the stress kinase JNK at Thr183/Tyr185, was 
significantly reduced by HT at 2hr recovery, compared to TN (p = 0.0030), 0hr recovery 
(p = 0.0286), and 24hr recovery (p = 0.0214) (Figure 5B). Though there was a significant 
decrease in both the p38 and JNK MAPK’s, other stress markers, such as IκBα and pNFκB 




A single bout of HT at 40°C for 2 hours alters autophagy signaling. When the heat 
duration was increased, similar findings were seen amongst the autophagy markers 
examined. Two hours of heating did not result in a significant increase in the levels 
phosphorylation of mTOR at Ser2448, compared to TN (Figure 6A). However, there was 
a significant decrease in mTOR phosphorylation at 24hr recovery (p = 0.0047) compared 
to 2hr recovery (Figure 6A). The phosphorylation of AMPK at Thr172, was significantly 
elevated by HT at 0hr (p = 0.0015) and 2hr (p = 0.0409) recovery compared to TN (Figure 
6B). The phosphorylation of ULK1 at Ser757 was unaltered by 2 hours of heat (Figure 6C). 
Whereas, the phosphorylation of ULK1 at Ser555 was significantly increased at 2hr 
recovery (p = 0.0385) compared to TN (Figure 6D). With 2 hours of heating, significant 
accumulation of LC3 II was observed at 24hr recovery group compared to TN (p = 0.0153) 
and 2hr recovery (p = 0.0332) (Figure 6E). In the BafA1 group, 2hr (p = 0.0255) and 24hr 
(p = 0.0165) recovery showed significantly elevated LC3 II levels compared to 0hr 
recovery (Figure 6F). The accumulation of p62 increased significantly at 2hr recovery 
compared to TN (p = 0.0024), 0hr recovery (p = 0.0159), and 24hr recovery (p = 0.0011) 
(Figure 6G). In the BafA1 treated group, p62 levels at 0hr recovery were significantly 
elevated compared to TN (p = 0.0394) and the 24hr recovery (p = 0.0070) (Figure 6H). 
Regulation of key autophagy proteins by 2 hours of 40°C HT. Despite the moderate 
changes in expression levels of key initiation and autophagosome proteins, there were no 
changes in any of the other key autophagy proteins, such as Atg3, Atg16L1, PI3K Class 
III, and Beclin-1 (Figure 7A-D). 
2 hours of heating at 40°C activates the heat shock response. After 2 hours of HT at 
40°C, HSF1 displayed significant hyperphosphorylation at 0hr recovery compared to TN 
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(p < 0.0001), 2hr recovery (p < 0.0001), and 24hr recovery (p < 0.0001) (Figure 8A). Two 
hours of heat showed a trend for increase at 0hr recovery (p = 0.0832), but exhibited 
significantly increased levels at 2hr (p = 0.0072) and 24hr (p = 0.0026) recovery, all 
compared to TN (Figure 8B). The phosphorylation of Hsp27 was significantly reduced at 
0hr recovery compared to TN (p = 0.0027), 2hr recovery (p = 0.0027), and 24hr recovery 
(p < 0.0001) (Figure 8C). In addition to being elevated compared to 0hr recovery, 24hr 
recovery showed significantly elevated phosphorylation of Hsp27 compared to TN (p = 
0.0033) and 2hr recovery (p = 0.0033) (Figure 8C). The total Hsp27 protein levels did not 
change significantly with HT (p > 0.1). There was no change in expression levels of the 
other small heat shock protein, αC-crystallin with HT (Figure 8D). 
Regulation of cell stress markers after heating for 2 hours at 40°C. With 2 hours of 
heating, p38 phosphorylation was significantly elevated at 0hr (p = 0.0051) and 2hr (p = 
0.0189) recovery compared to TN (Figure 9A). The phosphorylation of JNK at 
Thr183/Tyr185 was significantly elevated at 0hr recovery compared to TN (p = 0.0336), 
2hr recovery (p = 0.0034), and 24hr recovery (p = 0.0004) (Figure 9B). Additionally, the 
phosphorylation of JNK was reduced significantly at 24hr recovery (p = 0.0201) compared 
to TN (Figure 9B). Levels of IκBα did not change with 2 hours of heating (Figure 9C). 
However, the phosphorylation of NFκB at Ser536 was significantly elevated at 2hr (p = 
0.0111) recovery and significantly decreased at 24hr (p = 0.0182) recovery, compared to 
TN (Figure 9D). The 24hr recovery group was also significantly lower than both 0hr (p = 





Heat treatment can provide many benefits to skeletal muscle, such as reduced 
oxidative stress, improved insulin signaling, and increased mitochondrial biogenesis [11, 
12]. Heating of C2C12 skeletal muscle cells at 40°C for 1 hour has previously been shown 
to increase the phosphorylation of AMPK at T172, increase the transcription of PGC-1α, 
and activation of mitochondrial biogenesis [12]. We confirmed this finding and further 
demonstrated a single bout of 1 or 2 hours of HT upregulated autophagy initiation 
signaling, including phosphorylation of ULK1 Ser555. These changes coincided with 
elevated autophagosome formation, represented by the increased abundance of p62 and/or 
LC3 II. However, the amount of time that the cells were exposed to the elevated 
temperature seemed to alter the autophagosome markers differently, suggesting that the 
duration of heat exposure has an important impact on the cellular response. Additionally, 
HT was able to activate the heat shock response, demonstrated by the elevation in the 
phosphorylation of HSF1, which is necessary for its activation, and the inducible HSPs, 
Hsp70 and pHsp27. Our results indicate that heat duration regulates markers of cell stress, 
such as p38, JNK, and NFκB, differently in skeletal muscle cells, with an increased heat 
duration seemingly causing more stress to the cell. These results proved evidence that 
supports our hypothesis that HT can alter autophagy signaling in skeletal muscle cells. 
Skeletal muscle cells require efficient autophagic flux to allow for proper nutrient 
recycling and the removal of protein aggregates or dysfunctional organelles [13]. Proper 
initiation of autophagy is therefore vital for skeletal muscle homeostasis. The main protein 
attributed to autophagy initiation is ULK1 [14]. It is well established that mTOR and 
AMPK are direct upstream regulators of ULK1 phosphorylation and activation, each 
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having multiple sites to potentially target [15]. The ULK1 phosphorylation site, Ser555 
(pULK1S555), is an activation site, initiating autophagy signaling, and is phosphorylated by 
AMPK [15]. Whereas mTOR is responsible for phosphorylating the ULK1 
phosphorylation site, Ser757 (pULK1S757), which inhibits the autophagic initiation activity 
of ULK1 [15]. It has been shown that rapamycin, a potent inhibitor of mTOR activation, 
can initiate autophagic signaling by decreasing levels of pULK1S757 [15]. In the current 
study, we did not observe a HT effect on the phosphorylation of mTOR at Ser2448 
(pmTORS2448), which is indicative of its activation. However, we did see a trend of 
decreasing levels of pULK1S757 after 1 hour of HT. Activated AMPK, indicated typically 
by its phosphorylation at Thr172 (pAMPKT172), has been shown to increase pULK1S555, 
which is an essential step in activating autophagy in skeletal muscle [16]. It has also been 
suggested that pULK1S555 levels may be a more efficient indicator of ULK1 activity, than 
pULK1S757 levels [17]. With 12 hours of heat stress (HS), it was shown that in porcine 
skeletal muscle, pAMPKT172 and pULK1S555 levels were significantly elevated, but not 
changes were seen in pULK1S757 levels [18]. Here we additionally show that 1 hour of HT, 
as has been seen with exercise, elevated the levels of pAMPKT172 and pULK1S555 [17]. 
Future studies are needed to further investigate the difference between heat and exercise 
induced activation of ULK1. 
Though ULK1 activation is an essential step in the activation of autophagy, some 
studies have reported that under certain stressors, there may exist a dissociation of the 
autophagic pathway between initiation, autophagosome formation, and autophagosome 
degradation [19, 20]. The most commonly used methods of investigating the formation of 
autophagosomes is by looking at the changes in levels of LC3 II and p62 [21]. Though the 
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direct observation of autophagosome formation and degradation, using live cell confocal 
imaging or electron microscopy, is the most efficient method of measuring autophagic flux, 
simpler methods have been established and verified to provide confident results [22]. One 
such method is the examination of expression levels of the autophagic proteins, LC3 II and 
p62, via western blot analysis. Unfortunately, conclusions cannot be reached confidently 
unless an inhibitor of autophagy is used alongside the experimental treatment being 
investigated [22]. 
An elevation of LC3 II could indicate that autophagosome formation is upregulated, 
yet still efficiently being degraded, or it could indicate that autophagosome degradation is 
being inhibited [22]. If the degradation of autophagosomes was being inhibited by an 
experimental treatment, then it is expected that there would be no further elevation of LC3 
II levels when an autophagy inhibitor was added [23]. Alternatively, if the experimental 
treatment increases levels of LC3 II, and upon addition of an autophagy inhibitor, the levels 
of LC3 II increase even further, this would suggest that the experimental treatment is 
increasing autophagic flux [23]. Here, we show that 1 hour of HT significantly increased 
levels of LC3 II after 2 hours of recovery, potentially suggesting an increase in autophagic 
activity. However, to investigate whether this was an indication of increased autophagic 
flux or dysregulation, the autophagy inhibitor BafA1 was used concomitantly with HT, and 
significantly elevated levels of LC3 II versus HT without BafA1. This suggests that 1 hour 
of HT is increasing autophagic flux in skeletal muscle cells. Whereas an increase of LC3 
II may suggest an increase in autophagic activity, a decrease in LC3 II levels may suggest 
a decrease in autophagosome formation or an increase in autophagosome degradation [22]. 
Interestingly, our results showed that 1 hour of HT decreased the BafA1-induced increase 
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in levels of LC3 II immediately after HT and until at least 2 hours of recovery. This could 
be an indication that HT was partially dysregulating autophagy, increasing LC3 II 
accumulation, which was then further elevated by the treatment of the cells with BafA1. 
However, this might also indicate that HT provides the skeletal muscle cells with some 
protection against the inhibition of autophagy, particularly through the mechanism(s) used 
by BafA1. This is an interesting finding that warrants further investigation to find out which 
of the two effects are being applied by HT.  
We additionally showed that 1 hour of HT had no effect on levels of p62, though it 
was still significantly elevated with BafA1 treatment. Whereas in our 2 hour HT cells, p62 
was significantly elevated at 2 hours of recovery in control cells and immediately after HT 
in BafA1 treated cells. It should be noted that changes in levels of p62, though a commonly 
used second marker for autophagosome formation, can be cell type dependent and can even 
be unrelated to autophagic activity [22]. Despite not always being a reliable indicator of 
autophagic activity, the observed p62 accumulation suggests that autophagy is 
dysregulated by 2 hours of HT. It has been shown that 12 hours of HS increased levels of 
both LC3 II and p62, simultaneously, suggesting that autophagosome degradation was 
inhibited, causing a buildup of autophagosomes in skeletal muscle [18]. Knowing that 
skeletal muscle relies heavily on autophagy during times of stress, and that a significant 
amount of skeletal muscle diseases are correlated with dysregulated autophagy, it is clear 
that future studies are needed to understand exactly how HT might be providing a 
protective effect against autophagy inhibition in skeletal muscle. 
There is an abundant amount of cellular proteins that associate or regulate the 
autophagic pathway, but not all of them are inducible by heat [18]. One hour of HT did 
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significantly increase the levels of Beclin-1 by 2 hours of recovery, lasting until at least 24 
hours after HT, but was unaltered by 2hr of HT. The rise in Beclin-1 could be due to an 
increased need for unbound Beclin-1. When Beclin-1 is bound to Bcl-2, the pro-autophagy 
activity of Beclin-1 is inhibited [24]. Therefore, an increase in Beclin-1 expression without 
a concomitant increase in Bcl-2 expression would result in a rise of free Beclin-1 levels, 
able to further propagate autophagy signaling. Other proteins involved in autophagy 
signaling, such as Atg3, Atg16L1, and PI3K Class III, were unaffected by HT. Not 
surprisingly, since Atg3 and Atg16L1 are involved in, but not consumed by, the lipidation 
of LC3 II, there may not be an immediate necessity for an increase in their expression. 
Similarly, Beclin-1 and PI3K Class III may not have an immediate need to increase 
expression levels, since they are upstream kinases involved in the initiation of autophagy. 
However, in porcine skeletal muscle exposed to 12 hours of HS, PI3K Class III and Atg3 
were significantly elevated compared to TN [18]. This may suggest that the intermediate 
autophagic proteins are only susceptible to a greater amount of stress, in this case 
represented as heat duration. 
The heat shock response involves the activation of the heat shock factor 1 
transcription factor (HSF1) and the heat shock proteins (HSPs) [8]. HSPs have many 
cellular functions, such as folding nascent or unfolded proteins, preventing protein 
aggregation, and degrading proteins [25]. The hyperphosphorylation of HSF1 signifies the 
activation of its transcription factor activity [26]. Both 1 and 2 hours of HT resulted in a 
significant increase in HSF1 hyperphosphorylation immediately after heating that returned 
to baseline levels by 2 hours of recovery. We had previously seen that 15 minutes of 
recovery was enough for the HSF1 hyperphosphorylation to return to thermoneutral (TN) 
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levels (data not shown). HSF1 activation leads to the transcription of the inducible HSPs, 
Hsp70 and Hsp27 [27]. An in vivo analysis showed no changes in skeletal muscle Hsp70 
expression when pigs were exposed to 2, 4, and 6 hours of HS [28]. Whereas, with both 
HT durations, we observed a significant elevation of Hsp70 during recovery. This is likely 
due to the lag in time between HSF1 activation of HSP transcription and translation. The 
sHSP αC-crystallin, also referred to as HspB8, unlike other HSPs, is not a chaperone 
protein,  but instead can act as a facilitator of autophagy, aiding in the delivery of proteins 
to autophagosomes through specific binding to p62 [29]. However, we observed no 
significant changes in αC-crystallin expression by either heat duration. 
The phosphorylation status of Hsp27, at Ser82 (pHsp27S82), was significantly 
altered by both heat durations. Hsp27 phosphorylation does not activate or inhibit it, but 
merely alters its function in the cell. When Hsp27 is unphosphorylated, it inhibits the 
polymerization of F-actin by mimicking the monomeric G-actin and binding to the growing 
end of strand [30]. The phosphorylation of Hsp27 at Ser82 causes its dissociation from F-
actin, where it then has chaperone, anti-oxidant, and anti-apoptotic activity [31]. 
Immediately after both durations of HT, pHsp27S82 was significantly reduced, but 
increased during the recovery period. However, only with the higher heat load did 
pHsp27S82 levels increase significantly greater than the TN group by the end of the 24 hours 
of recovery. The elevated pHsp27S82 during recovery by the 2 hours of heating, but not the 
1 hour of heating, again suggests that a longer duration of heating induced a greater stress 
on the cells. The delayed increase in pHsp27S82 may allow the cell to conserve energy for 
essential cell survival responses. However, further examination into the cause of this 
immediate decrease in pHsp27S82 levels by HT is needed. 
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Finally, we investigated the impact of HT on several markers of cell stress, such as 
the p38 and JNK MAPKs, as well as the inflammatory-associated markers IκBα and NFκB. 
As stated earlier, heat is a hormetic stressor, so HT might induce stress signaling along 
with the other signaling pathways. The phosphorylation and activation of p38 at 
Thr180/Tyr182 (p-p38T180/Y183) and JNK at Thr183/Tyr185 (pJNKT183/Y185), can lead to 
cellular proliferation, inflammation, and/or apoptosis [32]. It has previously been shown 
that in porcine skeletal muscle after 2, 4, and 6 hours of HS, there were no changes in 
MAPK phosphorylation, IκBα expression, or the phosphorylation of NFκB at Ser536 
(pNFκBS536), but a significant elevation of total NFκB after 6 hours of HS [28]. In contrast, 
our results show that with 1 hour of HT, p-p38T180/Y183 and pJNKT183/Y185 were reduced 
immediately or after 2 hours of recovery by HT, which returned to baseline levels during 
the full recovery from heat. Whereas, with 2 hours of heat, p-p38T180/Y183 and pJNKT183/Y185 
were significantly elevated by HT, again returning to baseline levels during recovery. 
These results suggest that 1 hour of HT decreases skeletal muscle MAPK stress signaling, 
while 2 hours of HT increases it.  
Indirect downstream pro-inflammatory targets of p38 and JNK MAPKs, are IκBα 
and NFκB [33]. When IκBα becomes phosphorylated by IKK, IκBα is degraded and NFκB 
can then be activated by its phosphorylation at Ser536 [33]. The nuclear translocation of 
activated NFκB results in increased transcription of inflammatory and stress response 
genes, such as tumor necrosis factor α (TNFα), inducible nitric oxide synthase (iNOS), and 
cyclooxygenase-2 (COX-2) [34]. We saw no changes in the levels of IκBα or pNFκBS536 
with 1 hour of HT, suggesting that 1 hour of HT did not induce an inflammatory response. 
With 2 hours of HT, there was a similar lack of alteration to the levels of IκBα in the 
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skeletal muscle cells, but cells showed increased pNFκBS536 after 2 hours of recovery from 
the HT, which diminished during the remainder of the recovery period. These results agree 
with our MAPK data, further supporting the notion that 2 hours of HT induces cellular 
stress, while 1 hour of HT can prevent or not induce cellular stress signaling. 
 In conclusion, our study shows that, in C2C12 skeletal muscle cells, a single 1 hour 
bout of 40°C heat treatment can increase autophagy initiation and autophagosomal 
accumulation, activate the heat shock response, and decrease markers of cell stress. While 
2 hours of HT at 40°C potentially induced autophagic dysregulation and significantly 
increased markers of cells stress, suggesting that it may be less beneficial, or even 
damaging, to skeletal muscle than 1 hour of HT. While our data stem from cell culture 
experiments, and lack the systemic response to heat that would likely play a major role in 
the cellular response, our results still provide evidence that autophagy is altered by HT in 
skeletal muscle cells. Additionally, our results suggest that HT could be a beneficial 
therapeutic intervention to target autophagy signaling in skeletal muscle pathologies. 
Further studies are needed to directly investigate the potential difference in autophagic 
responses to varying heat loads and whether the activation of autophagy by heat can 
prevent or improve skeletal muscle pathologies, such as insulin resistance. 
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Figure 1. Myotube heat treatment experimental design. For the 1 hour heat treatment (HT) experiments, myotubes were placed into 
one of four groups, thermoneutral (TN), 1 hour HT with no recovery (0hr), 1 hour HT with 2 hours of recovery (2hr), or 1 hour HT with 
24 hours of recovery (24hr). Heating at 40°C began 1 hour prior to the amount of recovery time designated for the group. Bafilomycin 
A1 (BafA1) was added three hours prior to cell harvest for each group. The same design was performed for the 2 hour HT experiments. 
The lines next to the group name represent time spent in 37°C, from the start of the experiment. The gray (1hr HT) and black (2hr HT) 







Figure 2. Assessment of skeletal muscle autophagy signaling in response to 1 hour 40°C heat treatment. C2C12 myotubes were 
left at 37°C, thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 
hours (2hr), or 24 hours (24hr) post-heating. A simplification of the autophagy pathway is shown (A). Protein lysates of thermoneutral 
and heat treated myotubes were analyzed by western blot for autophagy signaling proteins: pmTORS2448 (B), pAMPKT172 (C), pULK1S757 
(D), and pULK1S555 (E). In addition to 1 hour 40°C HT, some myotubes were also exposed to 3 hours of Bafilomycin A1 (100 nM) 
treatment, to inhibit autophagy. Western blot analysis was conducted for autophagosome markers: LC3 II (F) and p62 (G). Western 
blots and the quantifications are shown for all proteins. Images were vertically sliced when samples were not run contiguous, but were 
run on the same gel, in the experiment and lanes were juxtaposed (separated by black lines). *p < 0.05 vs TN; †p < 0.1 vs TN; #p < 
0.05; +p < 0.05 for main effect of BafA1. Values are means ± SEM for three to six wells per group. 
 
 
Figure 3. 1hr 40°C heat treatment regulation of key autophagy proteins. C2C12 myotubes were left at 37°C, thermoneutral (TN), 
or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours (24hr) 
post-heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for the key autophagy proteins: 
Atg3 (A), Atg16L1 (B), PI3K Class III (C), and Beclin-1 (D). Western blots and the quantifications are shown for all proteins. Images 
were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment and lanes were juxtaposed 






Figure 4. Regulation of the heat shock response with 1hr 40°C heat treatment. C2C12 myotubes were left at 37°C, thermoneutral 
(TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours 
(24hr) post-heating. Illustration of HSF1 activation and induction of Hsp expression (A). Protein lysates of thermoneutral and heat 
treated myotubes were analyzed by western blot for the heat shock response proteins: HSF1 (B), Hsp70 (C), αC-crystallin (D), and 
pHsp27S82 (E). Western blots and the quantifications are shown for all proteins. Images were vertically sliced when samples were not 
run contiguous, but were run on the same gel, in the experiment and lanes were juxtaposed (separated by black lines). *p < 0.05 vs TN; 





Figure 5. Cell stress marker expression levels after 1hr 40°C heat treatment. C2C12 myotubes were left at 37°C, thermoneutral 
(TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours 
(24hr) post-heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for cell stress markers: 
p-p38T180/Y182 (A), pJNKT183/Y185 (B), IκBα (C), and pNFκBS536 (D). Western blots and the quantifications are shown for all proteins. 
Images were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment and lanes were 







Figure 6. Impact of 2 hours of heat treatment at 40°C on autophagy signaling. C2C12 myotubes were left at 37°C, thermoneutral 
(TN), or exposed to 40°C for 2 hours, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours 
(24hr) post-heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for autophagy signaling 
and autophagosome proteins: pmTORS2448 (A), pAMPKT172 (B), pULK1S757 (C), pULK1S555 (D), LC3 II (E), LC3 II+BafA1 (F), p62 
(G), and p62+BafA1 (H). Western blots and the quantifications are shown for all proteins. Images were vertically sliced when samples 
were not run contiguous, but were run on the same gel, in the experiment and lanes were juxtaposed (separated by black lines). *p < 
0.05 vs TN; #p < 0.05. Values are means ± SEM for three to six wells per group. 
 
 
Figure 7. 1hr 40°C heat treatment regulation of key autophagy proteins. C2C12 myotubes were left at 37°C, thermoneutral (TN), 
or exposed to 40°C for 2 hours, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours (24hr) 
post-heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for the key autophagy proteins: 
Atg3 (A), Atg16L1 (B), PI3K Class III (C), and Beclin-1 (D). Western blots and the quantifications are shown for all proteins. Values 





Figure 8. Heat shock response after 2 hours of 40°C heat treatment. C2C12 myotubes were left at 37°C, thermoneutral (TN), or 
exposed to 40°C for 2 hours, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), or 24 hours (24hr) post-
heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for the heat shock response proteins: 
HSF1 (A), Hsp70 (B), αC-crystallin (C), and pHsp27S82 (D). Western blots and the quantifications are shown for all proteins. Images 
were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment and lanes were juxtaposed 





Figure 9. Cell stress marker expression levels after 2 hours of 40°C heat treatment. C2C12 myotubes were left at 37°C, 
thermoneutral (TN), or exposed to 40°C for 2 hours, heat treatment (HT), with cell harvest occurring immediately (0hr), 2 hours (2hr), 
or 24 hours (24hr) post-heating. Protein lysates of thermoneutral and heat treated myotubes were analyzed by western blot for cell stress 
markers: p-p38T180/Y182 (A), pJNKT183/Y185 (B), IκBα (C), and pNFκBS536 (D). Western blots and the quantifications are shown for all 
proteins. Images were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment and lanes 
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Abstract 
Insulin resistance in skeletal muscle is a key feature of type 2 diabetes. Since 
skeletal muscle is the largest organ for insulin-stimulated glucose uptake, this can cause 
significant complications for type 2 diabetics. Exposure of skeletal muscle cells to saturated 
fatty acids leads to an excessive accumulation of both intracellular and extracellular fatty 
acids, which interfere with many essential cellular processes, including insulin signaling 
and autophagy. Autophagy, an essential intracellular degradative system used to remove 
unwanted or unnecessary cytosolic components, is becoming widely recognized for its part 
in maintaining cellular homeostasis. Here, we investigated the role autophagy plays in the 
heat-induced insulin sensitizing effects seen in skeletal muscle. C2C12 myotubes were 
treated with high glucose and palmitate (HG+Palm) for 24 hours and either maintained at 
37°C (thermoneutral; TN) or heated at 40°C H) for 1 hour. Myotubes were harvested 
immediately (0hr) or 24 hours (24hr) after HT. For a subset of the samples, an autophagy 
inhibitor, Bafilomycin A1, was added 3 hours prior to cell harvest at a concentration of 100 
nM. During recovery all cells were returned to 37°C. HG+Palm treatment reduced skeletal 
muscle insulin signaling, represented by decreased phosphorylation of AS160 at Thr642, 
increased inhibitory phosphorylation of IRS1 at Ser636/639, and decreased 
phosphorylation of Akt at Ser473. The decreased insulin signaling induced by HG+Palm 
was partially attenuated by HT, suggested by the reduction in inhibitory phosphorylation 
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of IRS1 and trending increase in the phosphorylation of Akt. The HT-induced mechanism 
behind this attenuation may be through the activation of autophagy (increased LC3 II and 
decreased p62 levels), reduction of cellular stress signaling (reduced phosphorylation of 
p38, JNK, and NFκB), or induction of the heat shock response (elevated levels of Hsp70). 
When exposed to both HG+Palm and an autophagy inhibitor, the heat-induced insulin 
improvements were removed. These data suggest that autophagy plays a role in the insulin 
sensitizing effects of HT. 
Introduction 
Type 2 diabetes (T2D) accounts for greater than 90% of the cases of diabetes in the 
United States, with more than 90% of those type 2 diabetics being overweight or obese [1]. 
T2D is closely associated with insulin resistance, which occurs when tissues, such as, the 
liver, skeletal muscle, and adipose, become resistant to the effects of circulating insulin [2]. 
Skeletal muscle accounts for roughly 70-80% of glucose uptake and if this tissue becomes 
insulin resistant, can have devastating consequences throughout the body [3, 4]. There are 
many risk factors for insulin resistance and T2D, including a sedentary lifestyle, unhealthy 
diet, and/or obesity [2]. There are also many pharmacological and non-pharmacological 
treatment options for T2D, insulin resistance, and obesity, which typically function by 
targeting similar intracellular pathways [5]. Exercise is an efficient therapeutic intervention 
that can improve insulin signaling [6]. However, not all the benefits associated with 
exercise may be due to the mechanical contraction of the skeletal muscle. During exercise, 
there is a rise in skeletal muscle and core body temperature [7, 8]. Heat treatment (HT) has 
recently been shown to improve insulin resistance in models of high-fat diet-induced 
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obesity, however the mechanisms that allow for these beneficial effects of heat are still not 
completely elucidated. 
A key mechanism that is thought to play a major role in the insulin sensitizing 
effects of heat, is the heat shock response [9]. The heat shock response begins with the 
activation of the heat shock factor 1 (HSF1) transcription factor, which increases 
transcription of the heat shock proteins (HSPs) [10]. The most inducible HSP is Hsp70, 
which aids in the refolding of intracellular proteins or guides the protein to the lysosome 
for degradation, which is called chaperone-mediated autophagy (CMA) [11]. Another 
important HSP is Hsp27 (murine Hsp25), which is part of the small HSP (sHSP) family. 
Hsp27 functions in actin dynamics and the prevention of intracellular protein aggregates 
[12]. It has been shown that in vivo heat treatment (HT) can improve insulin signaling in a 
high fat diet-induced obesity model, and this improvement correlates to elevations of HSPs 
and reductions in markers of cell stress and inflammation [9]. It is also well known that 
autophagy is closely related to the heat shock response and has also been shown to be 
elevated by heat in several cell types and tissues [13, 14]. There is abundant evidence that 
suggests that autophagic dysregulation can induce insulin resistance and that the elevation 
of autophagy correlates with the improvement in insulin sensitivity [15-18]. However, 
whether autophagy is involved in the heat-induced improvements of skeletal muscle insulin 
resistance, has yet to be investigated. 
This study aimed to address the molecular mechanisms involved in the insulin 
sensitizing effects of heat on skeletal muscle cells. Specifically, the role that autophagy 
might have in the heat-induced insulin sensitization. To do this, C2C12 skeletal muscle 
cells were exposed to high glucose and palmitate (HG+Palm) for 24 hours and given a bout 
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of heat treatment for 1 hour at 40°C, then allowed to recover for up to 24 hours post-
heating. The role of heat-induced regulation of autophagy was investigated as a potential 
protective effect that ameliorates insulin resistance in skeletal muscle cells. We 
hypothesized that heat would increase autophagic flux, leading to an improvement in 
skeletal muscle insulin signaling. 
Materials and methods 
Materials 
C2C12 myoblasts (CRL-1772™) were purchased from ATCC (Manassas, VA). 
Dulbecco's Modified Eagle's medium (DMEM), Penicillin-Streptomycin (P/S), fetal 
bovine serum (FBS), and horse serum (HS) were purchased from Invitrogen (Grand Island, 
NY). The L-Glutamine and Glucose solutions were purchased from ThermoFisher 
Scientific (Carlsbad, CA). Bafilomycin A1 (BafA1) was purchased from Tocris Bioscience 
(Minneapolis, MN). Palmitic acid was from Nu-chek Prep, Inc. (Elysian, MN). 
Cell culture 
Mouse C2C12 myoblasts (ATCC® CRL-1772™) were cultured at 37°C, with 5% CO2, in 
complete growth medium, containing: DMEM supplemented with 10% fetal bovine serum, 
1% L-Glutamine, and 1% P/S. Growth media was replenished every 24-48 hours and cells 
were passaged upon reaching 70-90% confluency. Once at 70-90% confluency, myoblasts 
were differentiated into myotubes by the replacement of growth media with differentiation 
media, containing normal glucose (5.5 mM) DMEM supplemented with 2% HS and 1% 




Treatment of cells 
Following differentiation, media was changed to fresh serum-free DMEM containing 
either BSA with normal glucose (5.5mM) or 0.4 mM BSA-palmitate plus high-glucose (25 
mM; HG+Palm). Briefly, BSA was used both to stabilize the insoluble fatty acids and to 
transport them into the cell. Control (Con) cells were exposed to 0.4 mM BSA, and fatty 
acid-treated cells to 0.4 mM palmitate at a 3:1 FFA:BSA molar ratio. Cells were exposed 
to BSA or HG+Palm for 24 h. Myotubes were either maintained at 37°C or given a single 
bout of 40°C heat treatment (HT) for 1 hour, by placing the cultures into an incubator at 
40°C, with recovery times of 0 and 24 hours (Figure 1). For the measurement of autophagy, 
the autophagy inhibitor, bafilomycin A1 (BafA1) was added at 100 nM for 3 hours. 
Approximately 15 minutes prior to cell harvesting, some cells were stimulated with 100 
nM insulin (INS). 
Cell lysate preparation 
Upon completion of the treatment protocol, the serum-free media was removed, and cells 
were washed twice on ice with phosphate buffered saline (PBS). Cells were then lysed with 
1X cell lysis buffer (Cell Signaling; Danvers, MA), containing 1X Halt Protease Inhibitor 
Cocktail (ThermoFisher Scientific; Waltham, MA) and 1X Phosphatase Inhibitor Cocktail 
3 (MilliporeSigma; Burlington, MA), and removed from wells using a sterile, double-
ended cell lifter (CellTreat Scientific Products; Pepperell, MA). Cellular debris was 
removed from lysates by centrifugation at ~20,000g for 15 minutes at 4°C, and the 
supernatant was removed and stored at -80°C until analysis. Protein concentrations were 




Western blot analysis 
Samples were prepared for western blot analysis by denaturation in Laemmli sample buffer 
(Bio-Rad; Hercules, CA), containing the reducing agent dithiothreitol (DTT), at 95°C for 
5-10 minutes. The prepared samples were equally loaded into 4-15%, 4-20%, or 8-16% 
Stain-Free Criterion TGX gels (Bio-Rad) to final protein amounts of 5-30 µg, per lane. 
After electrophoresis was complete, proteins were transferred to PVDF membranes 
(MilliporeSigma; Burlington, MA). To ensure proper electrophoresis and transfer of 
proteins, as well as obtain a measurement of total lane protein, membranes were subjected 
to Bio-Rad’s Stain-Free protocol to obtain an image of total lane protein [19]. Protein-
coated membranes were then blocked, in 5% fat-free milk in Tris-buffered saline 
containing 0.1% Tween-20 (TBS-T), for 1 hour at room temperature. After blocking, 
membranes were cut and probed with primary antibodies (1°) overnight at 4°C. Following 
1° incubation, membranes were washed with TBS-T and probed with HRP-linked anti-
rabbit or anti-mouse secondary antibodies (Cell Signaling), at a concentration of 1:2000-
1:5000, for 1 hour at room temperature. Western blot images were captured with the 
ChemiDoc™ XRS Imaging System (Bio-Rad), and images were analyzed using Image 
Lab™ 6.0 Software (Bio-Rad). Antibodies specific for specific for AMPKα (#2532), 
phospho-AMPKαT172 (#2531), phospho-AS160T642 (#8881), Cleaved Caspase-3 (#9661), 
phospho-GSK3βS9 (#5558), IκBα (#4814), phospho-IR-βT1150/1151 (#3024), IRS1 (#3407), 
phospho-IRS1S636/639 (#2388), phospho-JNKT183/Y185 (#4668), LC3A/B (#12741), mTOR 
(#2983), phospho-mTORS2448 (#2971), phospho-NFκBS536 (#3033), p38 (#9212), phospho-
p38T180/Y182 (#9211), phospho-ULK1S757 (#6888), and phospho-ULK1S555 (#5869), as well 
as the secondary horseradish peroxidase (HRP)-linked antibodies (#7074, #7076) were 
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purchased from Cell Signaling Technology. Antibodies specific for αC-crystallin (sc-
398395), p62 (sc-28359), Hsp27 (sc-13132), phospho-Hsp27S82 (sc-166693), and Hsp70 
(sc-24) were obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX). 
Statistics 
Data are presented as mean ± SEM. Statistical differences between groups were analyzed 
by Two-Way or Three-Way ANOVA. When appropriate, this was followed by a post hoc 
comparison using the Tukey test. Statistical significance was set to p < 0.05. 
Results 
Heat treatment (HT) alters markers of insulin signaling in C2C12 myotubes. We 
examined the effect of HT on insulin signaling markers in skeletal muscle cells with and 
without insulin stimulation. Tyrosine phosphorylation of the β component of the insulin 
receptor (IR-β) is necessary for its activation. This begins the complex intracellular 
signaling cascade that involves many steps, including key proteins Akt, a serine/threonine 
kinase, as well as a downstream target of Akt, Akt substrate of 160 kDa (AS160). 
Activation of AS160 leads to the translocation of vesicles containing the glucose 
transporter, GLUT4, to the plasma membrane, for proper skeletal muscle glucose uptake. 
There was a significant interaction (HT x INS) and main effect of HT for the inhibitory 
phosphorylation of insulin receptor substrate 1 (IRS1) at Ser636/639 (pIRS1S636/639) (p = 
0.018 and p = 0.0352) and the phosphorylation of Akt at S473 (pAktS473) (p = 0.0002 and 
p = 0.0001). All proteins had a significant main effect elevation in their expression by INS. 
When cells were not stimulated with insulin, HT did not alter the phosphorylation levels 
of any of the proteins investigated (Figure 2A-D). In insulin stimulated (INS) cells, the 
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phosphorylation levels of two of the proteins were altered by HT. Levels of pIRS1S636/639 
showed a trend to decrease compared to TN-INS (p = 0.0749) and were significantly 
reduced in 24hr-INS (p = 0.0165), compared to 0hr-INS (Figure 2B). The levels of 
pAktS473, a phosphorylation that is necessary for Akt activation, were elevated by HT at 
0hr-INS (p < 0.0001) and 24hr-INS (p = 0.0003) compared to TN-INS (Figure 2C). HT 
had no effect on levels of AS160 phosphorylation at Thr642 (pAS160T642) in either Con or 
INS cells (Figure 2D). 
High glucose and palmitate (HG+Palm) treatment blunts the insulin signaling 
pathway in skeletal muscle cells. There was a significant interaction (HT x HG+Palm) 
for pIRS1S636/639 in non-INS (p = 0.0010) and INS (p = 0.0201) cells, as well as a trending 
interaction effect for pAktS473 (p = 0.0620) for INS cells. There was a main effect of HT in 
non-INS and INS cells for pIRS1S636/639 (p = 0.0008 and p = 0.0117) and pAktS473 (p = 
0.0318 and p = 0.0012). Additionally, there was a main effect of HG+Palm on non-INS 
and INS cells for pIRS1S636/639 (p < 0.0001 and p < 0.0001), pAktS473 (p < 0.0001 and p < 
0.0001), and pAS160T642 (p = 0.0002 and p = 0.0015). Levels of pIR-βY1150/1151 were not 
significantly altered by HT or HG+Palm in non-INS or INS cells (Figure 3A and 3B). In 
non-INS, HG+Palm treated cells, levels of pIRS1S636/639 were significantly reduced by HT 
at 0hr (p = 0.0200) and 24hr (p = 0.0003) compared to TN, and at 24hr (p = 0.0094) 
compared to 0hr (Figure 3C). In INS, HG+Palm treated cells, pIRS1S636/639 levels showed 
a trend of reduction at 0hr (p = 0.0652) and significant reduction at 24hr (p = 0.0076) 
compared to TN (Figure 3D). Though in non-INS cells there was no effect of HT on levels 
of pAktS473, in INS cells there was a significant elevation in levels at 0hr (p = 0.0051) and 
24hr (p = 0.0149) compared to TN, as well as a trending elevation at 24hr (p = 0.0765) 
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when treated with HG+Palm (Figure 3E and 3F). Levels of pAS160T642 were not altered 
by HT or HG+Palm in Con or INS cells (Figure 3G and 3H). 
The heat-induced activation of the heat shock response is altered by HG+Palm. The 
heat shock response induces the expression of proteins that are essential for maintaining 
proper protein folding, refolding denatured proteins, and preventing or disrupting protein 
aggregation. Hsp70 and Hsp27, a part of the small HSP family, are two of the inducible 
HSPs that have vital roles in maintaining cellular homeostasis during times of stress. 
Another member of the sHSP family that has been shown to have a role in regulating the 
HSP-autophagy interaction, is αC-crystallin, also known as HspB8. There was a significant 
interaction (HT x HG+Palm), main effect of HG+Palm, and a main effect of HT on levels 
of Hsp70 (p = 0.0193, p = 0.0030, and p = 0.0056) and phosphorylation of Hsp27 at Ser82 
(pHsp27S82) (p = 0.0065, p = 0.0003, and p = 0.0009). HT caused a significant elevation in 
Hsp70 levels of Con cells at 24hr (p = 0.0078) compared to TN, but Hsp70 levels were not 
significantly different with HT in HG+Palm treated cells (Figure 4A). The expression 
levels of the sHSP, αC-crystallin, were unaltered by either HT or HG+Palm treatment 
(Figure 4B). In Con the levels of pHsp27S82 were significantly reduced at 0hr (p = 0.0079), 
compared to the TN, and these levels rose significantly by 24hr (p = 0.0018), compared to 
0hr (Figure 4C). Additionally, with HG+Palm, the levels of pHsp27S82 showed a trend of 
reduction at 0hr (p = 0.0722) compared to TN.  
HG+Palm alters the expression of key cell stress markers. To investigate the effects of 
HT, with and without HG+Palm treatment, on the levels of cell stress in skeletal muscle 
cells, we examined several key markers of cell stress and inflammation. There was a 
significant interaction (HT x HG+Palm) for the phosphorylation of the p38 MAPK at 
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Thr180/Tyr182 (p-p38T180/Y182) (p = 0.0066) and the phosphorylation of the MAPK, JNK, 
at Thr183/Tyr185 (pJNKT183/Y185) (p = 0.0111), as well as a trending interaction effect for 
Cleaved Caspase-3 (p = 0.0804). There was a main effect of HT for p-p38T180/Y182 (p = 
0.0077), pJNKT183/Y185 (p = 0.0177), the phosphorylation of NFκB at Ser536 (pNFκBS536) 
(p = 0.0028), and Cleaved Caspase-3 (p = 0.0339). Additionally, there was a main effect 
of HG+Palm for p-p38T180/Y182 (p = 0.0002), pJNKT183/Y185 (p < 0.0001), IκBα (p = 0.0380), 
the phosphorylation of GSK3β at Ser9 (pGSK3βS9) (p < 0.0001), and Cleaved Caspase-3 
(p = 0.0066). In Con cells, levels of p-p38T180/Y182 were reduced by HT at 0hr (p = 0.0193) 
compared to TN and elevated at 24hr (p = 0.0048) compared to 0hr (Figure 5A). HT had 
no effect on levels of pJNKT183/Y185 in Con cells, but in HG+Palm cells, HT significantly 
reduced pJNKT183/Y185 levels at 0hr (p = 0.0176) compared to TN, which were elevated at 
24hr (p = 0.0110) compared to 0hr (Figure 5B).  
The MAPKs are known cell stress markers that can lead to the activation of 
inflammatory transcription through multiple pathways, one being the activation of NFκB 
through the degradation of its direct inhibitor, IκBα. Levels of IκBα were not significantly 
altered by HT in Con or HG+Palm cells (Figure 5C). Levels of pNFκBS536 showed a trend 
of reduction by HT at 0hr (p = 0.0560) compared to TN in Con cells (Figure 5D). In 
HG+Palm cells, HT significantly reduced levels of pNFκBS536 at 0hr (p = 0.0291) 
compared to TN, which showed only a trend of reduction from TN levels at 24hr (p = 
0.0995) (Figure 5D). Levels of Levels of IκBα were not significantly altered by HT in Con 
or HG+Palm cells (Figure 5E).  The cleavage of caspase-3 was significantly increased at 
0hr (p 0.0304) compared to TN, in Con cells (Figure 5F). 
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Autophagy is dysregulated by HG+Palm and partially restored by heat. The initiation 
of autophagy, through the activation of ULK1, is regulated by two main proteins: mTOR, 
for ULK1 inhibition by phosphorylation at sites such as Ser757 (pULK1S757), and AMPK, 
for ULK1 activation by phosphorylation at sites such as Ser555 (pULK1S555). There was a 
significant interaction (HT x HG+Palm) for the phosphorylation of AMPK at Thr172 
(pAMPKT172) (p = 0.0151) and a trending interaction for the phosphorylation of mTOR at 
Ser2448 (pmTORS2448) (p = 0.0873). There was a main effect of HT for pAMPKT172 (p = 
0.0031) and a trending main effect of HT for pmTORS2448 (p = 0.0617). Additionally, there 
was a main effect of HG+Palm for pmTORS2448 (p < 0.0001), pAMPKT172 (p < 0.0001), 
pULK1S757 or (p = 0.0011), and pULK1S555 (p < 0.0001). Levels of pmTORS2448 were not 
altered by HT in Con cells, but showed a trend of reduction at 24hr compared to TN (p = 
0.0724) and 0hr (0.0994) in HG+Palm cells (Figure 6A). HT significantly increased levels 
of pAMPKT172 at 0hr (p = 0.0043) compared to TN in Con cells (Figure 6B). There was no 
effect of HT on levels of either pULK1S757 or pULK1S555 in Con or HG+Palm cells (Figure 
6D).  
There was a significant interaction of BafA1 x HG+Palm for LC3 II (p = 0.0006). 
There were significant interaction effects of Heat x HG+Palm and of Heat x BafA1 x 
HG+Palm for p62 (p = 0.0004 and p = 0.0278). There was a main effect of HT for LC3 II 
(p = 0.0242) and p62 (p < 0.0001). Additionally, there was a main effect of HG+Palm for 
LC3 II (p < 0.0001) and p62 (p < 0.0001). Within groups, there was no significant effect 
of HT on the levels of LC3 II (Figure 6E). In HG+Palm, HT showed a significant reduction 
of p62 levels at 24hr compared to the TN (p < 0.0001) and 0hr (p = 0.0006) (Figure 6F). 
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Heat-induced activation of autophagy partially alleviates the HG+Palm-induced 
insulin resistance. There was a significant interaction (BafA1 x HG+Palm) for 
pIRS1S636/639 (p = 0.0302) and a trending interaction for pIR-βY1150/1151 (p = 0.0868). There 
were main effects of BafA1 and HG+Palm for pIRS1S636/639 (p = 0.0031 and p < 0.0001) 
and pAS160T642 (p = 0.0205 and p < 0.0001). There was no effect of HT, HG+Palm, BafA1, 
or HG+Palm+BafA1 on levels of pIR-βY1150/1151 (Figure 7A). Whereas HG+Palm induced 
an increase in pIRS1S636/639 levels in TN (p = 0.0169), HT attenuated this effect at 24hr (p 
= 0.0029) (Figure 7B). Interestingly, in HG+Palm when autophagy was inhibited, by the 
addition of BafA1, the HT-induced reduction of pIRS1S636/639 was lost (p = 0.0043) (Figure 
7B). Levels of pAktS473 showed no alterations by HG+Palm or HT (Figure 7C).  Heat had 
not affect on levels of pAS160T642, but there was a main effect of significant reduction by 
HG+Palm (p < 0.0001) compared to Con cells (Figure 7D). 
Discussion 
Exposure of skeletal muscle cells to saturated fatty acids such as palmitate, can lead 
to intracellular lipid accumulation that ultimately induces insulin resistance, which has 
been shown to impair key metabolic cellular processes such as autophagy [17, 20-22]. 
Acute bouts of heat treatment (HT) have been shown to improve insulin signaling, decrease 
oxidative stress, reduce inflammatory markers, and increase mitochondrial biogenesis [9, 
23]. In vivo heat treatment of high-fat diet fed rats demonstrated that only one bout per 
week (20 minutes at 41°C), for 12-weeks, is sufficient to significantly improve skeletal 
muscle glucose uptake, increase insulin signaling, elevate HSP expression, and decrease 
the activation of the stress kinases JNK and IKK-β [9]. Additionally, the in vitro heat 
treatment (1 hour at 40°C) of C2C12 myotubes, has been shown to induce mitochondrial 
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biogenesis, via the activation of the AMPK-SIRT1-PGC-1α pathway [23]. The heating of 
mice at 40°C for 30 min, 5 days per week for 3 weeks, demonstrated that the heat-induced 
mitochondrial biogenesis in skeletal muscle also occurred in vivo [24]. Autophagy 
signaling has also been shown to be upregulated by heat (30 minutes at 43°C) at a much 
higher temperature, in several cell lines [13]. Our lab has previously shown that heat 
treatment (1 hour at 40°C) of C2C12 myotubes increases markers for autophagy initiation 
and autophagosome formation [25]. However, the effects of HT on autophagy signaling in 
conditions of nutrient excess is not established. The data presented in this study 
demonstrate that high glucose and palmitate (HG+Palm) impairs markers of insulin 
signaling, elevates markers of cellular stress, and increases autophagosome accumulation. 
Additionally, we demonstrate that HT can attenuate the HG+Palm-induced reduction of 
skeletal muscle insulin signaling, which is mediated, at least in part, by autophagy. 
In the absence of heat, the upregulation of autophagy signaling by the addition of 
carnitine has been shown to improve insulin resistance (improved levels pAktS473 and 
pIRS1Y612) in the skeletal muscles of high fat-diet fed mice, suggesting that autophagy is 
indeed a modulator of insulin signaling [26]. Upregulation of autophagy typically begins 
with the initiation stage of autophagy, which is carried out through the activation status of 
ULK1 [27]. A ULK1 inhibitory site, Ser757, is phosphorylated by mTOR, whereas an 
activation site, Ser555, is phosphorylated by AMPK [27]. The phosphorylation of mTOR 
at Ser2448 and AMPK at Thr172, are markers of their activation [28]. When human aortic 
endothelial cells were treated with HG+Palm, autophagy initiation became impaired, 
suggested by the decreased levels of pAMPKT172 and pULK1S555 [29]. This impairment in 
autophagy rendered the cells more susceptible to apoptosis, all of which was attenuated by 
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the addition of rapamycin, the mTOR inhibitor and autophagy activator [29]. However, the 
use of AMPK activators, such as AICAR, on HG+Palm treated cells were not capable of 
restoring pULK1S555 or autophagosome levels, suggesting that AMPK becomes uncoupled 
from autophagy in these cells under nutrient-rich conditions [29]. In agreement with these 
observations, our results showed that HG+Palm reduced autophagy initiation in C2C12 
myotubes. When cells were treated with HG+Palm, there was an elevation in the levels of 
pmTORS2448 and a reduction in the levels of pAMPKT172. Similar to our previous findings, 
HT of Con cells acutely increased the levels of pAMPKT172 [25]. However unlike our 
previous findings, HT of Con cells did not increase levels of pULK1S555 [25]. The addition 
of BSA to our Con cells, to match that in the HG+Palm in the current study, may have 
contributed to these discrepant findings.  
 Exercise is a potent activator of skeletal muscle autophagy, and the induction of 
autophagy has been suggested to contribute to the beneficial effects of exercise [30, 31]. 
Although exercise has obvious physiological benefits, an individual whom is incapable or 
cannot maintain adherence to exercise, would greatly benefit from another physiological 
intervention. When type 2 diabetic patients sat in a hot tub (37.8 - 41.0°C) for 30 minutes 
a day, six days a week, for three weeks, there was an improvement in insulin sensitivity 
and a decrease in fasting blood glucose levels [32]. Though the mechanism behind these 
effects was not examined, another study showed that an elevation in Hsp70 levels can 
protect against insulin resistance and hyperglycemia in mice [33]. When human subjects 
were exposed to either active (1 hour of cycling at a fixed rate of metabolic heat production) 
or passive (1 hour of 40°C water immersion) heating, the elevation of extracellular Hsp70 
(eHsp70) expression and reduction in the glucose area under the curve compared to the 
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control subjects, was nearly identical between the interventions, suggesting that passive 
heating may be a viable alternative to exercise for treating certain metabolic diseases [34]. 
These data suggest that heat may be an effective alternative therapy to exercise, and that 
these effects may be brought about through HSP expression, however HSPs are not the 
only pathway activated by heat in skeletal muscle. 
The serine/threonine kinase, glycogen synthase kinase-3 (GSK3) is named for its 
activation of glycogen synthase, it is now known to regulate many critical cellular 
functions, such as transcription, apoptosis, ER stress, caspase-3 activation, and 
inflammation [35, 36]. In human aortic endothelial cells (HAECs) HG+Palm induces 
hyperactivity of GSK3β, leading to decreased lysosomal and autophagic activity, whereas 
the reduction of GSK3β activity resulted in increased LC3 II, decreased p62, increased 
pAMPKT172, and decreased levels of pAktS473 [37]. In contrast, our results showed that 
HG+Palm treatment increased the inhibitory phosphorylation of GSK3β at Ser9 and 
elevated both LC3 II and p62 levels. Furthermore, the addition of the autophagy inhibitor 
Bafilomycin A1 (BafA1) did not further elevate either LC3 II or p62 levels, suggesting that 
HG+Palm treatment dysregulates autophagosomal degradation. HT did not alter LC3 II 
levels under any condition, but attenuated the HG+Palm-induced accumulation of p62 after 
24 hours of recovery. These results suggest that HT may be able to partially rescue the 
impairment in autophagosomal degradation caused by HG+Palm. Further investigation is 
necessary to discern where in the pathway the dysregulation by HG+Palm and the HT-
induced benefits on skeletal muscle autophagy are occurring. 
HSP expression is suggested to be the prime driver of the physiological benefits of 
exercise and heat stress [9, 38], however the heat-induced elevation of HSP expression 
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does not always correlate with the metabolic benefits of heat [39, 40]. Additionally, HSP 
expression can be induced in response to many cellular stressors, other than heat, including 
oxidative stress, hypoxia, and inflammation [41]. HG+Palm significantly elevated TN 
expression of Hsp70 and prevented its HT-induced upregulation at 24 hours of recovery 
that was seen in Con cells. The elevation of Hsp70 expression has been shown to be 
induced by damaging and non-damaging stress to prevent or remedy protein misfolding, 
protein aggregation, oxidative stress, and overall cellular integrity [33, 42]. One 
mechanism that Hsp70 uses to protect the cell from stress, is through chaperone-mediated 
autophagy (CMA), which directs proteins to the lysosome for degradation [43]. The sHSP 
αC-crystallin, also referred to as HspB8, acts as a facilitator of autophagy, aiding in the 
delivery of proteins to autophagosomes through specific binding to p62 [44]. However, 
there was not alteration to αC-crystallin by either HG+Palm or HT. Whereas HT caused an 
immediate reduction in the phosphorylation of another sHSP, Hsp27 at Ser82, that was 
slightly attenuated by the addition of HG+Palm. Unphosphorylated Hsp27 acts as an actin-
binding cap, inhibiting actin polymerization, which requires ATP [45, 46]. Phosphorylation 
of Hsp27 removes it from actin, allowing actin to polymerize, and giving Hsp27 its 
chaperone, anti-oxidant, and anti-apoptotic activity [47]. Our results showed that levels of 
pHsp27S82 were reduced immediately by heat, but increased during recovery. We also 
showed that HG+Palm prevented the increase in pHsp27S82 levels during recovery. These 
data suggest that HG+Palm is activating the heat shock response through another 
mechanism other than heat (increased Hsp70 with HG+Palm) and interfering with the HSP 




Non-insulin stimulated glucose uptake occurs in response to muscular contraction, 
but has also been shown in response to heat [48, 49]. Our results show that when skeletal 
muscle cells were exposed to heat and were also insulin stimulated (INS), HT immediately 
increased the phosphorylation of Akt and decreased the inhibitory Serine phosphorylation 
of IRS1 at S636/639 during the recovery period. The addition of HG+Palm to the cells 
attenuated the HT-induced elevation of pAktS473, significantly increased levels of 
pIRS1S636/639, and decreased levels of pAS160T642, but HT still significantly reduced the 
HG+Palm-induced elevation of pIRS1S636/639 levels. HG+Palm treatment reduced levels of 
pAktS473, elevated levels of pIRS1S636/639, and reduced levels of pAS160T642, suggesting 
that less insulin signaling and GLUT4 trafficking to the membrane was occurring. These 
results indicate that HG+Palm induced dysregulation of the insulin signaling pathway and 
that 1 hour of 40°C HT may have partially benefited the cell, but was insufficient to fully 
restore insulin signaling. The ex vivo heating of skeletal muscle, at 42°C for 10 minutes, 
increased glucose uptake, pAMPKT172 levels, and AMPK activity, but had no effect on 
levels of pIR-βY1158/1162/1163 or pAktS473 [49]. Thus, when skeletal muscle cells in vitro or 
skeletal muscle ex vivo HT experiments are conducted, perhaps a larger heat load is 
necessary to observe similar results obtained from in vivo heating studies. 
HT was able to attenuate the HG+Palm-induced elevation of pIRS1S636/639 and p62 
levels during recovery, particularly at 24 hours. Inhibition of autophagy with BafA1 
significantly increased the HT-induced reduction of pIRS1S636/639 levels at 24hr. This 
suggests that heat-induced autophagy is involved in the reduction of IRS1 inhibition, 
potentially improving insulin signaling. The heat load used in the current study might have 
been too mild to compensate completely for the HG+Palm load used, potentially explaining 
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the lack of HT-induced alterations in other insulin signaling proteins investigated. 
Investigation of varying HT and HG+Palm treatment loads would allow for a better 
understanding on their load relationship. Our current study also used in vitro models to 
study the effects of HT on autophagy and insulin signaling, which eliminated any 
additional physiological extracellular stimuli from HT to regulate the intracellular 
signaling of the skeletal muscle cells. Rats that we unilaterally denervated and exposed to 
either a single bout or multiple bouts of heat stress (42°C for 30 minutes) showed increased 
Hsp70 expression, PGC-1α expression, and levels of pAktS473, in the innervated skeletal 
muscle only [50]. This suggests that skeletal muscle intracellular signaling is highly 
regulated by extracellular physiological stimuli, when exposed to heat. Additionally, other 
studies have examined the effects of in vivo or in vitro HT with multiple bouts, whereas 
we examined the effects of only a single bout. It could be that skeletal muscle insulin 
resistance may require multiple bouts of HT to see any beneficial effects [9]. It warrants 
further investigation to see at what heating duration and/or regime, would insulin signaling 
begin to be improved in skeletal muscle and whether autophagy has a role. 
The phosphorylation of the MAPKs, p38 and JNK, have many different functions 
that seem stressor dependent. For example, in some instances, p38 phosphorylation could 
induce inflammation, whereas other studies have shown that p38 phosphorylates Hsp27 to 
activate actin polymerization and the Hsp27 cell-survival functions [51, 52]. Similar to 
p38, JNK activation has a multitude of functions that seem to be stress dependent, but it is 
commonly associated with the induction of inflammation [52]. Downstream pro-
inflammatory proteins of JNK are IκBα and NFκB [53]. IκBα binds to and inhibits the 
activation of NFκB. When IκBα is phosphorylated by IKK, it dissociates from NFκB and 
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IκBα is then degraded [54]. This allows for NFκB to become phosphorylated and 
translocate to the nucleus, where it will induce the transcription of inflammatory proteins 
[55]. In HeLa cells, it has been suggested that the activation of the NFκB is crucial for cell 
survival of heat stress (90 minutes at 43°C), by its activation of autophagy [56]. NFκB 
incompetent cells did not show activation of autophagy and showed elevated cell death, 
however this could be prevented in these cells by the artificial induction of autophagy [56]. 
In contrast, other studies have shown that in human osteocarcinoma cells, heat stress (1 
hour at 43°C) inhibits the activation of the NFκB pathway, but that this inhibition is not 
through activation of HSF1 or HSP transcription [57, 58]. We show here that the addition 
of HG+Palm to skeletal muscle cells reduced the expression levels of IκBα, which was 
unaltered by HT. There was a concurrent elevation in NFκB phosphorylation at Ser536 by 
HG+Palm, that HT reduced immediately. These results suggest that HT may be a potential 
tool to counter the HG+Palm-induced inflammation of skeletal muscle cells. 
In conclusion, this study suggests that dysregulated autophagy is involved in the 
HG+Palm-induced insulin resistance, and that heat treatment may protect skeletal muscle 
cells against insulin resistance, in part, through regulation of autophagy. Future studies 
should focus on understanding the mechanism by which HT regulates autophagy in insulin 
resistant skeletal muscle. Though HT is a promising therapeutic application for insulin 
resistance, further studies are needed to identify its full potential physiological benefits and 
how it might impact skeletal muscle autophagy and insulin resistance in vivo. 
References 
1. Control, C.f.D. and Prevention, National diabetes statistics report, 2017. Atlanta, GA: 
Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2017. 
114 
 
2. Hardy, O.T., M.P. Czech, and S. Corvera, What causes the insulin resistance underlying 
obesity? Current opinion in endocrinology, diabetes, and obesity, 2012. 19(2): p. 81. 
3. DeFronzo, R.A. and D. Tripathy, Skeletal muscle insulin resistance is the primary defect 
in type 2 diabetes. Diabetes care, 2009. 32(suppl 2): p. S157-S163. 
4. Hong, S., et al., Relative muscle mass and the risk of incident type 2 diabetes: A cohort 
study. PloS one, 2017. 12(11): p. e0188650. 
5. Coughlan, K.A., et al., AMPK activation: a therapeutic target for type 2 diabetes? Diabetes 
Metab Syndr Obes, 2014. 7: p. 241-53. 
6. Ivy, J.L., Role of exercise training in the prevention and treatment of insulin resistance and 
non-insulin-dependent diabetes mellitus. Sports medicine, 1997. 24(5): p. 321-336. 
7. Saltin, B., A.t. Gagge, and J. Stolwijk, Muscle temperature during submaximal exercise in 
man. Journal of applied physiology, 1968. 25(6): p. 679-688. 
8. Saltin, B., et al., Body temperatures and sweating during exhaustive exercise. Journal of 
applied physiology, 1972. 32(5): p. 635-643. 
9. Gupte, A.A., et al., Heat treatment improves glucose tolerance and prevents skeletal 
muscle insulin resistance in rats fed a high-fat diet. Diabetes, 2009. 58(3): p. 567-78. 
10. Vihervaara, A. and L. Sistonen, HSF1 at a glance. 2014, The Company of Biologists Ltd. 
11. Kaushik, S., et al., Constitutive activation of chaperone-mediated autophagy in cells with 
impaired macroautophagy. Mol Biol Cell, 2008. 19(5): p. 2179-92. 
12. Kötter, S., et al., Human myocytes are protected from titin aggregation-induced stiffening 
by small heat shock proteins. J Cell Biol, 2014. 204(2): p. 187-202. 
13. Zhao, Y., et al., Induction of macroautophagy by heat. Mol Biol Rep, 2009. 36(8): p. 2323-
7. 
14. Swanlund, J.M., K.C. Kregel, and T.D. Oberley, Autophagy following heat stress: the role 
of aging and protein nitration. Autophagy, 2008. 4(7): p. 936-939. 
15. Liu, J., et al., PGRN induces impaired insulin sensitivity and defective autophagy in hepatic 
insulin resistance. Molecular Endocrinology, 2015. 29(4): p. 528-541. 
16. Liu, X., et al., AMPK binds to Sestrins and mediates the effect of exercise to increase 
insulin-sensitivity through autophagy. Metabolism-Clinical and Experimental, 2015. 
64(6): p. 658-665. 
17. Dagon, Y., C. Mantzoros, and Y.B. Kim, Exercising insulin sensitivity: AMPK turns on 
autophagy! Metabolism, 2015. 64(6): p. 655-7. 
18. Kim, K.H. and M.S. Lee, Autophagy--a key player in cellular and body metabolism. Nat 
Rev Endocrinol, 2014. 10(6): p. 322-37. 
115 
 
19. Ghosh, R., J.E. Gilda, and A.V. Gomes, The necessity of and strategies for improving 
confidence in the accuracy of western blots. Expert review of proteomics, 2014. 11(5): p. 
549-560. 
20. Aas, V., et al., Lipid metabolism in human skeletal muscle cells: effects of palmitate and 
chronic hyperglycaemia. Acta Physiologica, 2005. 183(1): p. 31-41. 
21. Schmitz-Peiffer, C., D.L. Craig, and T.J. Biden, Ceramide generation is sufficient to 
account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle 
cells pretreated with palmitate. Journal of Biological Chemistry, 1999. 274(34): p. 24202-
24210. 
22. Shi, L., et al., Dihydromyricetin improves skeletal muscle insulin resistance by inducing 
autophagy via the AMPK signaling pathway. Mol Cell Endocrinol, 2015. 409: p. 92-102. 
23. Liu, C.-T. and G.A. Brooks, Mild heat stress induces mitochondrial biogenesis in C2C12 
myotubes. Journal of Applied Physiology, 2012. 112(3): p. 354-361. 
24. Tamura, Y., et al., Postexercise whole body heat stress additively enhances endurance 
training-induced mitochondrial adaptations in mouse skeletal muscle. American Journal 
of Physiology-Regulatory, Integrative and Comparative Physiology, 2014. 307(7): p. 
R931-R943. 
25. Summers, C.M. and R.J. Valentine, Heat treatment elevates markers of autophagy 
signaling and reduces markers of cell stress in C2C12 myotubes. In Preparation, 2018. 
26. Choi, J.W., et al., Carnitine induces autophagy and restores high-fat diet-induced 
mitochondrial dysfunction. Metabolism-Clinical and Experimental, 2018. 78: p. 43-51. 
27. Mizushima, N., The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin 
Cell Biol, 2010. 22(2): p. 132-9. 
28. Alers, S., et al., Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, 
shortcuts, and feedbacks. Mol Cell Biol, 2012. 32(1): p. 2-11. 
29. Weikel, K.A., et al., Glucose and palmitate uncouple AMPK from autophagy in human 
aortic endothelial cells. Am J Physiol Cell Physiol, 2015. 308(3): p. C249-63. 
30. He, C., et al., Exercise-induced BCL2-regulated autophagy is required for muscle glucose 
homeostasis. Nature, 2012. 481(7382): p. 511-515. 
31. He, C., J. Sumpter, Rhea, and B. Levine, Exercise induces autophagy in peripheral tissues 
and in the brain. Autophagy, 2012. 8(10): p. 1548-1551. 
32. Hooper, P.L., Hot-tub therapy for type 2 diabetes mellitus. New England Journal of 
Medicine, 1999. 341(12): p. 924-925. 
33. Chung, J., et al., HSP72 protects against obesity-induced insulin resistance. Proceedings 
of the National Academy of Sciences, 2008. 105(5): p. 1739-1744. 
34. Faulkner, S.H., et al., The effect of passive heating on heat shock protein 70 and 




35. Jope, R.S., C.J. Yuskaitis, and E. Beurel, Glycogen synthase kinase-3 (GSK3): 
inflammation, diseases, and therapeutics. Neurochemical research, 2007. 32(4-5): p. 577-
595. 
36. Song, L., P. De Sarno, and R.S. Jope, Central role of glycogen synthase kinase-3β in 
endoplasmic reticulum stress-induced caspase-3 activation. Journal of Biological 
Chemistry, 2002. 277(47): p. 44701-44708. 
37. Weikel, K.A., et al., Knockdown of GSK3beta increases basal autophagy and AMPK 
signalling in nutrient-laden human aortic endothelial cells. Biosci Rep, 2016. 36(5). 
38. Kim, K.-B., M.-H. Kim, and D.-J. Lee, The effect of exercise in cool, control and hot 
environments on cardioprotective HSP70 induction. Journal of physiological anthropology 
and applied human science, 2004. 23(6): p. 225-230. 
39. Naito, H., et al., Heat stress-induced changes in skeletal muscle: Heat shock proteins and 
cell signaling transduction. The Journal of Physical Fitness and Sports Medicine, 2012. 
1(1): p. 125-131. 
40. Kojima, A., et al., Heat stress facilitates the regeneration of injured skeletal muscle in rats. 
Journal of Orthopaedic Science, 2007. 12(1): p. 74. 
41. Dokladny, K., O.B. Myers, and P.L. Moseley, Heat shock response and autophagy—
cooperation and control. Autophagy, 2015. 11(2): p. 200-213. 
42. Lewis, E.J., et al., Mild eccentric exercise increases Hsp72 content in skeletal muscles from 
adult and late middle-aged rats. Cell Stress and Chaperones, 2013. 18(5): p. 667-673. 
43. Cuervo, A.M. and E. Wong, Chaperone-mediated autophagy: roles in disease and aging. 
Cell Res, 2014. 24(1): p. 92-104. 
44. Rusmini, P., et al., Clearance of the mutant androgen receptor in motoneuronal models of 
spinal and bulbar muscular atrophy. Neurobiology of aging, 2013. 34(11): p. 2585-2603. 
45. Lomiwes, D., et al., Small heat shock proteins and their role in meat tenderness: A review. 
Meat Science, 2014. 96(1): p. 26-40. 
46. Korn, E.D., M.-F. Carlier, and D. Pantaloni, Actin polymerization and ATP hydrolysis. 
Science, 1987. 238(4827): p. 638-644. 
47. Concannon, C., A. Gorman, and A. Samali, On the role of Hsp27 in regulating apoptosis. 
Apoptosis, 2003. 8(1): p. 61-70. 
48. Kramer, H.F., et al., AS160 regulates insulin-and contraction-stimulated glucose uptake in 
mouse skeletal muscle. Journal of Biological Chemistry, 2006. 281(42): p. 31478-31485. 
49. Goto, A., et al., Heat stress acutely activates insulin‐independent glucose transport and 5′‐
AMP‐activated protein kinase prior to an increase in HSP72 protein in rat skeletal muscle. 
Physiological reports, 2015. 3(11). 
50. Ohira, T., et al., The effects of heat stress on morphological properties and intracellular 




51. Larsen, J.K., et al., Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase 
and MAPKAP kinase in smooth muscle. American Journal of Physiology-Lung Cellular 
and Molecular Physiology, 1997. 273(5): p. L930-L940. 
52. Sui, X., et al., p38 and JNK MAPK pathways control the balance of apoptosis and 
autophagy in response to chemotherapeutic agents. Cancer Lett, 2014. 344(2): p. 174-9. 
53. Levine, B., N. Mizushima, and H.W. Virgin, Autophagy in immunity and inflammation. 
Nature, 2011. 469(7330): p. 323-35. 
54. Schulze-Osthoff, K., et al., Regulation of NF-κB activation by MAP kinase cascades. 
Immunobiology, 1997. 198(1-3): p. 35-49. 
55. Kramer, H.F. and L.J. Goodyear, Exercise, MAPK, and NF-kappaB signaling in skeletal 
muscle. J Appl Physiol (1985), 2007. 103(1): p. 388-95. 
56. Nivon, M., et al., Autophagy activation by NFκB is essential for cell survival after heat 
shock. Autophagy, 2009. 5(6): p. 766-783. 
57. Janus, P., et al., Cross talk between cytokine and hyperthermia-induced pathways: 
identification of different subsets of NF-κB-dependent genes regulated by TNFα and heat 
shock. Molecular Genetics and Genomics, 2015. 290(5): p. 1979-1990. 
58. Janus, P., et al., NF‐κB signaling pathway is inhibited by heat shock independently of active 
transcription factor HSF1 and increased levels of inducible heat shock proteins. Genes to 






Figure 1. Heat treatment (HT) experimental design. Myotubes were placed into one of several groups, thermoneutral (TN), TN plus 
high glucose and palmitate (TN-HG/Palm), HT with no recovery (0hr), HT with no recovery plus HG+Palm (0hr-HG/Palm), HT with 
24 hours of recovery (24hr), or HT with 24 hours of recoverey plus HG+Palm (24hr-HG/Palm). Heating at 40°C began 1 hour prior to 
the amount of recovery time designated for the group. Bafilomycin A1 (BafA1) was added three hours prior to cell harvest, while insulin 
stimulation (INS) occurred 15 minutes prior to cell harvest, for each group. The lines next to the group name represent time spent at 
37°C in either BSA (Con) or HG-Palm. The white box on the lines indicates time spent at 40°C. The dotted box indicates duration of 
BafA1 treatment. The shaded area represents INS treatment. 
 
 
Figure 2. Assessment of skeletal muscle insulin signaling in response to 1 hour 40°C heat treatment. C2C12 myotubes were left at 
37°C, thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr) or 24 hours 
(24hr) post-heating. Protein lysates of BSA-treated (Con) and BSA-treated and insulin stimulated (INS) cells, were analyzed by western 
blot for pIR-βY1150/1151 (A), pIRS1S636/639 (B), pAktS473 (C), and pAS160T642 (D). Western blots and the quantifications are shown for all 
proteins. Images were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment and lanes 
were juxtaposed (separated by black lines). *p < 0.05 vs TN; #p < 0.05 vs 0hr; +p < 0.05 for main effect of INS vs Con. Values are 







Figure 3. Effect of HG+Palm treatment on insulin signaling markers after heat treatment, with and without insulin stimulation. 
C2C12 myotubes were left at 37°C, thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring 
immediately (0hr) or 24 hours (24hr) post-heating. Protein lysates of BSA-treated (Con) and high glucose plus palmitate-treated 
(HG+Palm) cells, without (left column) and with (right column) insulin stimulation (INS), were analyzed by western blot for pIR-
βY1150/1151 (A & B), pIRS1S636/639 (C & D), pAktS473 (E & F), and pAS160T642 (G & H). Western blots and the quantifications are shown 
for all proteins. Images were vertically sliced when samples were not run contiguous, but were run on the same gel, in the experiment 
and lanes were juxtaposed (separated by black lines). *p < 0.05 vs TN; †p < 0.1 vs TN; #p < 0.05 vs 0hr; +p < 0.05 for main effect of 
HG+Palm vs Con. Values are means ± SEM for two to six wells per group. 
 
 
Figure 4. Regulation of the heat shock response with heat treatment, in the presence of HG+Palm. C2C12 myotubes were left at 
37°C, thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr) or 24 hours 
(24hr) post-heating. Protein lysates of BSA-treated (Con) and high glucose plus palmitate-treated (HG+Palm) cells, were analyzed by 
western blot for Hsp70 (A), αC-crystallin (B), and pHsp27S82 (C). Western blots and the quantifications are shown for all proteins. *p < 
0.05 vs TN; †p < 0.1 vs TN; #p < 0.05 vs 0hr; +p < 0.05 for main effect of HG+Palm vs Con. Values are means ± SEM for two to six 





Figure 5. Alteration of cell stress marker levels after heat treatment, in the presence of HG+Palm. C2C12 myotubes were left at 
37°C, thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr) or 24 hours 
(24hr) post-heating. Protein lysates of BSA-treated (Con) and high glucose plus palmitate-treated (HG+Palm) cells, were analyzed by 
western blot for p-p38T180/Y182 (A), pJNKT183/Y185 (B), IκBα (C), pNFκBS536 (D), pGSK3βS9 (E), and Cleaved Caspase-3 (F). Western blots 
and the quantifications are shown for all proteins. *p < 0.05 vs TN; †p < 0.1 vs TN; #p < 0.05 vs 0hr; +p < 0.05 for main effect of 





Figure 6. Impact of HG+Palm treatment and heat treatment on autophagy signaling. C2C12 myotubes were left at 37°C, 
thermoneutral (TN), or exposed to 40°C for 1 hour, heat treatment (HT), with cell harvest occurring immediately (0hr) or 24 hours 
(24hr) post-heating. Protein lysates of BSA-treated (Con) and high glucose plus palmitate-treated (HG+Palm) cells, were analyzed by 
western blot for pmTORS2448 (A), pAMPKT172 (B), pULK1S757 (C), pULK1S555 (D), LC3 II (E), and p62 (F). Further analyses of LC3 II 
(E) and p62 (F) were performed on cells treated with HG+Palm, BafA1, and the combination of HG+Palm and BafA1 
(HG+Palm+BafA1). *p < 0.05 vs TN; †p < 0.1 vs TN; #p < 0.05 vs 0hr; ‡p < 0.1 vs 0hr; +p < 0.05 for main effect vs Con. Values are 





Figure 7. HG+Palm-induced autophagy dysregulation and insulin resistance in response to heat treatment. C2C12 myotubes 
were exposed to 40°C for 1 hour, heat treatment (HT), allowed to recover for 24 hours (24hr), and stimulated with insulin. Protein 
lysates of cells exposed to BSA (Con), high glucose plus palmitate (HG+Palm), bafilomycin A1 (BafA1), or HG+Palm and BafA1 were 
analyzed by western blot for pIR-βY1150/1151 (A), pIRS1S636/639 (B), pAktS473 (C), and pAS160T642 (D). Western blots and the quantifications 
are shown for all proteins. Images were vertically sliced when samples were not run contiguous, but were run on the same gel, in the 
experiment and lanes were juxtaposed (separated by black lines). Two-Way ANOVA was performed only on HT cells with 24hr 
recovery (4 bars on the right of the division line). TN-Con and TN-HG+Palm (2 bars on the left of the division line) are presented for 
reference and normalization. *p < 0.05 vs 24hr-Con; †p < 0.1 vs 24hr-Con. +p < 0.05 main effect of HG+Palm; ∆p < 0.05 main effect 




CHAPTER 5.    CONCLUSIONS AND FUTURE DIRECTIONS 
 Firstly, we examined the effects that an acute bout of heat treatment would have on 
autophagy signaling in C2C12 myotubes. We performed the heat treatment at two different 
heat loads: (1) 40°C for 1 hour and (2) 40°C for 2 hours. Both heat loads increased 
autophagy initiation, which was shown by increased phosphorylation of AMPK, increased 
phosphorylation of the activation site of ULK1, and decreased inhibitory phosphorylation 
of ULK1. Both heat durations also caused alterations in the levels of the autophagosome 
marker, LC3 II. With 1 hour of heat treatment, LC3 II levels went up immediately, but 
returned to thermoneutral levels during the 24 hours of recovery. To investigate whether 
this was an indication of increased autophagic flux or dysregulation, the autophagy 
inhibitor BafA1 was used concomitantly with HT. The HT-induced elevation of LC3 II 
was further increased, suggesting that HT is activating autophagy, not inhibiting 
autophagosomal degradation. However, we additionally saw a decrease in levels of LC3 II 
by HT in the BafA1 treated cells. This was a particularly interesting finding, that could 
indicate a protective effect of HT against autophagy inhibition or that HT partially 
dysregulates autophagy. Further investigation is needed in order to find out which of the 
two effects are being applied by HT. 
Other autophagy proteins were examined, of which Beclin-1 showed increased 
expression 2 hours after the 1 hour heating. Both heat durations also activated the heat 
shock response, shown by the hyperphosphorylation of HSF1, increase in Hsp70, and 
alteration in Hsp27 phosphorylation. To determine whether heat treatment was altering the 
intracellular stress signaling, several stress response markers were examined. The 
activation of p38 and JNK both significantly decreased with 1 hour of heat treatment, 
125 
 
whereas the 2 hours of heat treatment showed an elevation of these stress markers. This 
may suggest that 2 hours at 40°C may be too stressful for the cells, or it could simply mean 
that it is a greater stress that will become beneficial during recovery. There was a significant 
reduction in JNK activation and NFκB phsophorylation after 24 hours of recovery versus 
thermoneutral, suggesting it was beneficial after recovery. 
 Secondly, we examined the effects that heat treatment for 1 hour at 40°C would 
have on insulin sensitization, in insulin resistant skeletal muscle cells. Here we showed that 
without insulin resistance, heat could increase the insulin signaling upon stimulation. When 
palmitate was added to the cells, insulin signaling significantly dropped and heat treatment 
improved some markers of insulin resistance, while not altering others. The addition of 
palmitate increased cell stress markers, and heat treatment showed a therapeutic effect by 
decreasing some of the stress protein expression. Palmitate also significantly blunted the 
initiation of autophagy and autophagosomal degradation. Heat treatment did not seem to 
overcome the inhibition of the initiators of autophagy, but it caused a decrease in the 
palmitate-induced accumulation of both p62 and LC3 II. After 24 hours of recovery from 
heat treatment, cells showed a decreased expression of the inhibitory phosphorylation of 
IRS1, which was returned to thermoneutral levels upon the addition of BafA1. This 
suggests that heat-induced autophagy has some beneficial role in improving insulin 
signaling in insulin resistant skeletal muscle tissue. 
 These studies have several limitations and several avenues that are worth further 
exploration. Though it is not typically custom to investigate the mRNA levels of autophagy 
proteins, limiting our study to only protein investigation could have left out important 
details about what heat was doing inside the cells. One of the most efficient methods for 
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autophagy examination is the use of green fluorescent protein labeled LC3 and live-cell 
imaging. This technique would, allow for greater confidence in our results if it verified our 
assumptions of autophagic upregulation by heat, or it might allow us to see whether 
autophagy plays much of a role at all. The use of western blot analysis is a gold-standard 
technique for protein investigation, but it is limited to a “snapshot” of what is occurring 
inside the cells. Further investigation using fluorescent labeling and live-cell imaging 
would reveal a better understanding of autophagic regulation, in real time, by heat. Going 
forward, taking these studies into an animal model would prevent any limitations from in 
vitro work. The whole body responds to stressors, such as heat, and when performing this 
research in a cell culture, we are losing any external effects that might activate the pathway 
that we are investigating. It would be interesting to also compare the effects of exercise 
versus the effects of heat treatment in vivo. This would give us an understanding on what 
proportion of the beneficial effects of exercise are from heat production and what 
proportion are from skeletal muscle contraction. 
 The investigation of the molecular mechanisms that govern the improvement in 
insulin resistance is an important area of research. Some therapeutic options, such as 
exercise, caloric restriction, heat, or medications, for preventing or treating type II diabetes 
may not be suitable or efficient for every individual. Understanding the mechanisms that 
are at work in these interventions would allow for better therapeutic targeting for future 
therapies. Though our studies have their limitations, it is obvious that heat alters autophagy 
signaling. Since autophagy plays such a critical role in maintaining cellular homeostasis 
and can be stress-induced, this pathway could be providing much of the insulin sensitizing 
effects that is seen with heat treatment, however further examination is needed. 
